<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2014</YEAR>
<VOL>12</VOL>
<NO>2</NO>
<MOSALSAL>45</MOSALSAL>
<PAGE_NO>192</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Human 3-D tissue models in radiation biology: current status and future perspectives</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>In this review, we discuss the use of a variety of 3-D models (particularly 3-D skin, lung, breast and endothelial) in radiobiological research and highlight the differences in responses compared to 2-D culturing conditions (monolayers). We review the characteristics of existing 3-D models and aim to point out the substantial advantages 3-D cultures provide for modern radiobiology. In particular, they may facilitate the shift from the classical DNA damage and repair studies mainly carried out in monolayer cultures to the investigation of more generalized responses through pathway analysis and a system biology approach. 3-D models are expected to be very informative for investigations on radiotherapy responses in addressing the low dose risk. However, the 3-D model systems are not as easy to propagate and standardize as monolayer cultures. Therefore, we discuss the problems and limitations of 3-D models and propose ways to overcome some of the problems.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>81</FPAGE>
			<TPAGE>98</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>A.</Name>
				<MidName></MidName>
				<Family>Acheva</Family>
				<NameE>A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Acheva</FamilyE>
				<Organizations>
				<Organization>STUK - Radiation and Nuclear Safety Authority, Laippatie 4, 00880 Helsinki, Finland</Organization>
				</Organizations>
				<Countries>
				<Country>Finland</Country>
				</Countries>
				<EMAILS>
				<Email>Anna.Acheva@stuk.fi</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.</Name>
				<MidName></MidName>
				<Family>Aerts</Family>
				<NameE>A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aerts</FamilyE>
				<Organizations>
				<Organization>SCK•CEN - Belgian Nuclear Research Centre, Radiobiology Unit, Boeretang 200, B-2400 Mol, Belgium</Organization>
				</Organizations>
				<Countries>
				<Country>Belgium</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ch.</Name>
				<MidName></MidName>
				<Family>Rombouts</Family>
				<NameE>Ch.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rombouts</FamilyE>
				<Organizations>
				<Organization>SCK•CEN - Belgian Nuclear Research Centre, Radiobiology Unit, Boeretang 200, B-2400 Mol, Belgium</Organization>
				</Organizations>
				<Countries>
				<Country>Belgium</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.</Name>
				<MidName></MidName>
				<Family>Baatout</Family>
				<NameE>S.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Baatout</FamilyE>
				<Organizations>
				<Organization>SCK•CEN - Belgian Nuclear Research Centre, Radiobiology Unit, Boeretang 200, B-2400 Mol, Belgium</Organization>
				</Organizations>
				<Countries>
				<Country>Belgium</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.</Name>
				<MidName></MidName>
				<Family>Salomaa</Family>
				<NameE>S.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Salomaa</FamilyE>
				<Organizations>
				<Organization>STUK - Radiation and Nuclear Safety Authority, Laippatie 4, 00880 Helsinki, Finland</Organization>
				</Organizations>
				<Countries>
				<Country>Finland</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>K.</Name>
				<MidName></MidName>
				<Family>Manda</Family>
				<NameE>K.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Manda</FamilyE>
				<Organizations>
				<Organization>Department of Radiotherapy and Radiation Oncology, University Hospital Rostock, Südring 75, D-18059 Rostock, Germany</Organization>
				</Organizations>
				<Countries>
				<Country>Germany</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>G.</Name>
				<MidName></MidName>
				<Family>Hildebrandt</Family>
				<NameE>G.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hildebrandt</FamilyE>
				<Organizations>
				<Organization>Department of Radiotherapy and Radiation Oncology, University Hospital Rostock, Südring 75, D-18059 Rostock, Germany</Organization>
				</Organizations>
				<Countries>
				<Country>Germany</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.</Name>
				<MidName></MidName>
				<Family>Kämäräinen</Family>
				<NameE>M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kämäräinen</FamilyE>
				<Organizations>
				<Organization>STUK - Radiation and Nuclear Safety Authority, Laippatie 4, 00880 Helsinki, Finland</Organization>
				</Organizations>
				<Countries>
				<Country>Finland</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>3-D tissue models</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>radiation biology</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##1.  Schmeichel KL, and  Bissell  MJ (2003)  Modeling tissue-specific signaling and organ function in three dimensions. Journal of Cell Science, 116(12): 2377-2388. ##2. Eke I and Cordes N (2011) Radiobiology goes 3D: How ECM and cell morphology impact on cell survival after irradiation. Radiotherapy and Oncology, 99(3): 271-278. ##3.  Barcellos-Hoff  MH, Aggeler J, Ram TG, Bissell MJ (1989) Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development, 105(2): 223-235. ##4.  Debnath  J, Muthuswamy  SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods, 30(3): 256-268. ##5.  Dietrich  F  and Lelkes P (2006)  Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in fibrin and collagen gels. Angiogenesis, 9(3): 111-125. ##6. Pageau SC, Sazonova  OV, Wong  JY, Soto  AM, Sonnenschein C (2011) The effect of stromal components on the modulation of the phenotype of human bronchial epithelial cells in 3D culture. Biomaterials, 32(29): 7169-7180. ##7.  Vernon RB and Sage EH (1999) A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvascular Research, 57(2): 118-133. ##8.  Yamauchi  M., Oka Y, Yamamoto M, Niimura K, Uchida M, Kodama S et al. (2008) Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling. DNA Repair, 7(3): 405-417. ##9. Tsunenaga M, Kohno Y, Horii I, Yasumoto S, Huh N, Tachikawa T, et al. (1994) Growth and differentiation properties of normal and transformed human keratinocytes in organotypic culture. Cancer Science, 85(3): 238-244. ##10. Shim JW, Park CH, Bae YC, Bae JY, Chung S, Chang MY, Koh HC, Lee HS, Hwang SJ, Lee KH, Lee YS, Choi CY, Lee SH (2007. Generation of functional dopamine neurons from neural precursor cells isolated from the subventricular zone and white matter of the adult rat brain using Nurr1 overexpression. Stem Cells, 25:1252-62.##11.  Marshall GP, Ross HH, Suslov O, Zheng T, Steindler DA,  Laywell ED (2008) Production of neurospheres from CNS tissue. Methods Mol Biol, 438:135-50. ##12.  Balic  M, Rapp N, Stanzer S, Lin H, Strutz J, Szkandera J, Daidone MG, Samonigg H, Cote RJ, Dandachi N (2011. Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells. Appl Immunohistochem Mol Morphol, 19: 33-40. ##13. Paranjape AN, Mandal T, Mukherjee G, Kumar MV,   Sengupta K,  Rangarajan A (2012) Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene 31(15):1896-909, doi: 10.1038/onc 2011.378.##14. Kaji H, Camci-Unal G, Langer R, Khademhosseini A (2010). Engineering systems for the generation of patterned co-cultures for controlling cell-cell interactions. Biochim Biophys Acta,  1810(3): 239-50.##15. Hirschi KK and D'Amore PA (1996)  Pericytes in the microvasculature. Cardiovasc Res, 32(4): 687-98.##16. Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NF, Wheatley DN (1999)  An in-vitro model of angiogenesis: basic features. Angiogenesis, 3(4): 335-44.##Donovan D, Brown NJ, Bishop ET, Lewis CE (2001). Comparison of three in-vitro human 'angiogenesis' assays with capillaries formed in-vivo. Angiogenesis 4(2): 113-21.##Rainger GE and Nash GB (2001) Cellular pathology of atherosclerosis: smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res, 88(6): 615-22.##19. Wallace CS and Truskey GA (2010) Direct-contact co-culture between smooth muscle and endothelial cells inhibits TNF-alpha-mediated endothelial cell activation. Am J Physiol Heart Circ Physiol,  299(2): H338-46.##20.  Tarallo S, Beltramo E, Berrone E, Porta M (2012) Human pericyte-endothelial cell interactions in co-culture models mimicking the diabetic retinal microvascular environment. Acta Diabetol, 49 Suppl 1: S141-51.##21.  Anfuso CD, Lupo G, Romeo L, Giurdanella G, Motta C, Pascale A, Tirolo C, Marchetti B, Alberghina M (2007) Endothelial cell-pericyte cocultures induce PLA2 protein expression through activation of PKCalpha and the MAPK/ERK cascade. J Lipid Res, 48(4): 782-93.##22.  Zozulya A, Weidenfeller C, Galla HJ (2008). Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in-vitro. Brain Res, 1189: 1-11.##23.  Miki Y, Ono K, Hata S, Suzuki T, Kumamoto H, Sasano H (2012) The advantages of co-culture over mono cell culture in simulating in-vivo environment. J Steroid Biochem Mol Biol, 131(3-5): 68-75.##24. Jahns J, Anderegg U, Saalbach A, Rosin B, Patties I, Glasow A, Kamprad M, Scholz M, Hildebrandt G. (2011). Influence of low dose irradiation on differentiation, maturation and T-cell activation of human dendritic cells. Mutat Res, 709-710: 32-39.##25 Cao MD, Chen ZD, Xing Y (2004) Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction. Cell Biol  Int, 28: 223–228.##26.  van der Worp HB, Howells DW, Sena ES, Porritt  MJ, Rewell S, O'Collins V et al. (2010) Can animal models of disease reliably inform human studies? PLoS Med 7(3): e1000245.: Public Library of Science. ##27. Barcellos-Hoff  MH (2008) Cancer as an emergent phenomenon in systems radiation biology. Radiation and Environmental Biophysics, 47:33–38.##28.  Barcellos-Hoff MH (1998) How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues. Rad Res,150(5 Suppl): S109-S120.##29.  Stark  H, Baur  M, Breitkreutz D, Mirancea N, Fusenig NE (1999) Organotypic keratinocyte cocultures in defined medium with regular epidermal morphogenesis and differentiation. J Invest Dermatol, 112(5): 681-691.##30.  Asselineau D and Prunieras M (1984) Reconstruction of 'simplified' skin: Control of fabrication. British Journal of Dermatology, 111: 219-222. ##31. Fartasch M  and Ponec M (1994) Improved barrier structure formation in air-exposed human keratinocyte culture systems. J Investig Dermatol, 102(3): 366-374. ##32. Koo JS, Yoon JH, Gray T, Norford D, Jetten  AM, Nettesheim P (1999) Restoration of the Mucous Phenotype by Retinoic Acid in Retinoid-Deficient Human Bronchial Cell Cultures: Changes in Mucin Gene Expression. American Journal of Respiratory Cell and Molecular Biology, 20: 1, 43-52.##33. van Wetering S, Zuyderduyn S, Ninaber DK, van Sterkenburg MA, Rabe KF, Hiemstra PS, (2007) Epithelial differentiation is a determinant in the production of eotaxin-2 and -3 by bronchial epithelial cells in response to IL-4 and IL-13. Molecular Immunology, 44: 5, 803-811.##34.  Delgado O, Kaisani AA, Spinola M, Xie X-J, Batten KG, et al. (2011) Multipotent capacity of immortalized human bronchial epithelial cells. PLoS ONE 6(7): e22023. ##35.  Asaithamby A, Hu B, Delgado  O, Ding  L, Story MD, Minna JD et al. (2011)  Irreparable complex DNA double-strand breaks induce chromosome breakage in organotypic three-dimensional human lung epithelial cell culture. Nucleic Acids Research, 39(13): 5474-5488.##36. Debnath J and Brugge JS (2005) Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer, 5: 675-688.##37. Hebner C, Weaver VM, Debnath J (2008) Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures, Annu. Rev Pathol, 3: 313-339.##38.  Vidi PA, Bissell MJ, Lelievre SA (2013) Three-dimensional culture of human breast epithelial cells: the how and the why, Methods. Mol Biol, 945: 193-219.##39. Bissell MJ and Bilder D (2003) Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin 1. Breast Cancer Res, 5: 117-119.##40. Lo AT, Mori H, Mott J, Bissell MJ (2012)  Constructing three-dimensional models to study mammary gland branching morphogenesis and functional differentiation. J  Mammary  Gland  Biol Neoplasia, 17:  103-110.##41.  Xu R, Boudreau A, Bissell MJ (2009) Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices.  Cancer Metastasis Rev, 28: 167-176.##42.  Huss FR and Kratz G (2001) Mammary epithelial cell and adipocyte co-culture in a 3-D matrix: the first step towards tissue-engineered human breast tissue, Cells Tissues. Organs, 169:  361-367.##43.  Wang X,  Zhang X, Sun L, Subramanian B, Maffini MV, Soto A, Sonnenschein C, Kaplan DL, (2009)  Preadipocytes stimulate ductal morphogenesis and functional differentiation of human mammary epithelial cells on 3D silk scaffolds. Tissue Eng Part A, 15:  3087-3098.##44.  Campbell JJ, Davidenko N, Caffarel MM, Cameron RE, Watson CJ (2011) A multifunctional 3D co-culture system for studies of mammary tissue morphogenesis and stem cell biology. PLoS One,  6: e25661.##45.  Krause S, Maffini MV, Soto AM, Sonnenschein C (2008)  A novel 3D in-vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C. Methods, 14:  261-271.##46.  Angelucci C, Maulucci G, Lama G, Proietti G, Colabianchi A, Papi M, Maiorana A, De SM, Micera  A, Balzamino  OB, Di  LA, Masetti R, Sica G (2012) Epithelial-stromal interactions in human breast cancer: effects on adhesion, plasma membrane fluidity and migration speed and directness. PLoS  One, 7:  e50804.##47.  Wang X, Sun L, Maffini  MV, Soto A, Sonnenschein C, Kaplan DL (2010) A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function. Biomaterials, 31:  3920-3929.##48. Martineau L and Doillon CJ (2007)  Angiogenic response of endothelial cells seeded dispersed versus on beads in fibrin gels. Angiogenesis, 10(4): 269-77.##49. Aranda E and Owen GI (2009) A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol Res, 42(3): 377-89.##50.  Korff T and Augustin HG (1998) Integration of Endothelial Cells in Multicellular Spheroids Prevents Apoptosis and Induces Differentiation. The Journal of Cell Biology, 143(5): 1341‐1352.##51.  Infanger M, Kossmehl P, Shakibaei M, Baatout S, Witzing A, Grosse J, Bauer J, Cogoli A, Faramarzi S, Derradji H, Neefs M, Paul M, Grimm D (2006) Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: Impact of vascular endothelial growth factor. Apoptosis, 11(5): 749-764.##52.  Sanford GL, Ellerson D, Melhado-Gardner C, Sroufe AE, Harris-Hooker S (2002) Three-dimensional growth of endothelial cells in the microgravity-based rotating wall vessel bioreactor. In-vitro cell dev biol-animal, 38(9): 493-504.##53.  Auerbac R, Lewis R, Shinners B, Kubai L, Akhtar N (2003). Angiogenesis assays: a critical overview.  Clinical chemistry, 49(1):32-40.##54. Hall EJ and  Giaccia A (2006) Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott Williams &#38; Wilkins.##55.  Suzuki K, Nakashima M, Yamashita S (2010) Dynamics of ionizing radiation-induced DNA damage response in reconstituted three-dimensional human skin tissue. Radiation Research, 174 (4):415-423.##56 . Sowa MB, Chrisler WB, Zens KD, Ashjian EJ, Opresko LK (2010) Three-dimensional culture conditions lead to decreased radiation induced cytotoxicity in human mammary epithelial cells.  Mutation Research, 687:78–83. ##57.  Sedelnikova OA, Nakamura  A, Kovalchuk  O, Koturbash I, Mitchell SA, Marino SA  et al. (2007)  DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Research, 67(9): 4295-4302. ##58.  Redon CE, Dickey JS, Bonner WM, Sedelnikova OA (2009) [gamma]-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. Advances in Space Research, 43(8):1171-1178.##59. Ghandhi S, Yaghoubian B, Amundson  S (2008) Global gene expression analyses of bystander and alpha particle irradiated normal human lung fibroblasts: Synchronous and differential responses. BMC Medical Genomics, 1(1): 63. ##60.  Mezentsev A and Amundson SA (2011) Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model. Radiation Research, 175(6): 677-688. ##61.  Yunis  R, Albrecht  H, Kalanetra KM, WU  S, Rocke  DM (2012) Genomic characterization of a three-dimensional skin model following exposure to ionizing radiation. Journal of Radiation Research, 53(6): 860-875. ##62.  Kotsianos  D, Bach D, Gamarra  F, Haimerl  W, Knüchel  R,  Lang  SM  et al. (2000) High-dose-rate brachytherapy: Dose escalation in three-dimensional miniorgans of the human bronchial wall. International Journal of Radiation Oncology*Biology*Physics, 46(5): 1267-1273. ##63.  Bergner A, Stief  J, Holdenrieder S, Stieber  P, Haimerl  W, Passlick  B  et al. (2003) Effects of single-dose irradiation on bronchial epithelium: A comparison of BEAS 2B cell monolayers, human organ cultures, and goettinger minipigs.  Radiation Research, 160(6): 647-654. ##64. Park  CC, Henshall-Powell RL, Erickson AC, Talhouk  R, Parvin B, Bissell  MJ et al. (2003) Ionizing radiation induces heritable disruption of epithelial cell interactions. Proceedings of the National Academy of Sciences, 100(19):10728-10733. ##65.  Andarawewa  KL, Erickson  AC, Chou  W S, Costes  SV, Gascard  P, Mott  JD   et al. (2007) Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor β–Induced epithelial to mesenchymal transition. Cancer Research, 67(18): 8662-8670. ##66.  Andarawewa  KL, Costes SV, Fernandez-Garcia I, Chou WS, Ravani SA, Park H et al. (2011) Lack of radiation dose or quality dependence of epithelial-to-mesenchymal transition (EMT) mediated by transforming growth factor β. International Journal of Radiation Oncology Biology Physics, 79(5): 1523-1531. ##67.  Nguyen  D, Oketch-Rabah H, Illa-Bochaca I, Geyer F, Reis-Filho J, Mao J et al. (2011) Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell, 19(5): 640-651.##68.  Pang  R and Poon R (2006)  Clinical implications of angiogenesis in cancers. Vascular Health and Risk Management, 2(2): 97-108. ##69.  Sonveaux P, Brouet A, Havaux X, Gregoire V, Dessy C, Balligand JL, Feron O (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res, 63(5): 1012-9.##70.  Annabi  B, Lee  Y, Martel  C, Pilorget  A, Bahary J, Boliveau R (2003) Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Cbt, 2(6): 640-647. ##71.  Sofia Vala I, Martins LR, Imaizumi N, Nunes RJ, Rino J, Kuonen F, Carvalho LM, Ruegg C, Grillo IM, Barata JT et al.(2010) Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS One, 5(6): e11222.##72 Khurana R, Simons M, Martin JF, Zachary IC (2005)  Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation, 112(12): 1813-24.##73.  Imaizumi N, Monnier Y, Hegi M, Mirimanoff RO, Ruegg C (2010)  Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PLoS One, 5(6): e11084.##74.  Grabham P, Hu B, Sharma P, Geard C (2011)  Effects of ionizing radiation on three-dimensional human vessel models: differential effects according to radiation quality and cellular development. Radiat Res, 175(1): 21-8.##75.  Schettino  G, Johnson  GW, Marino  SA, Brenner  DJ (2010) Development of a method for assessing non-targeted radiation damage in an artificial 3D human skin model. Int J Radiat Biol, 86(7): 593-601. ##76.  Shay  JW and Wright WE. (2005) Use of telomerase to create bioengineered tissues. Annals of the New York Academy of Sciences, 1057(1): 479-491.##77. Dickson  MA, Hahn  WC, Ino Y, Ronfard  V, Wu  JY, Weinberg  RA  et al. (2000)  Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Molecular and Cellular Biology, 20(4): 1436-1447. ##78 .Tomanek RJ and Schatteman GC (2000) Angiogenesis: new insights and therapeutic potential. Anat Rec, 261(3): 126-35.##79.  Upreti M, Jamshidi-Parsian A, Koonce NA, Webber JS, Sharma SK, Asea AA, Mader MJ, Griffin RJ (2011) Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics. Transl Oncol, 4(6):365-376.##80  Storch K, Eke I, Borgmann K, Krause M, Richter K, Becker K, Schröck E, Cordes N (2010)  Three-dimensional cell growth confers radioresistance by chromatin density modification  Cancer Res, 70: 3925–3934.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Protective effects of sulfated derivatives of polysaccharides extracted from Auricularia auricular on hematologic injury induced by radiation</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Ionizing radiation induces the production of reactive oxygen species (ROS), which play an important causative role in cell death. The aim of this study was to investigate the protective effects of sulfated derivatives of neutral polysaccharides extracted from Auricularia auricular (SNAAP).  Materials and Methods: Whole blood samples from healthy donors treated with SNAAP at different concentrations (20, 60, 100 &#38;mug/mL) were exposed to various doses of X-rays. Wistar rat spleen lymphocytes, in cultures, were treated with SNAAP at different concentrations (20, 60, 100 &#38;mug/mL) in the presence p.o 12 hours prior to 8 Gy gamma radiation exposure. Animals were administered with SNAAP at doses of 50, 100 or 200 mg/kg body weight d p.o 7 days prior to sub-lethal doses (6 Gy) of whole body gamma radiation exposure. Results: SNAAP is an effective radio protector against X-ray radiation induced in vitro cellular damage in human peripheral blood. Furthermore, to support this finding the effect of SNAAP on a rat&#8217;s spleen lymphocytes, when cultured and examined 24 hours after exposure to 8 Gy &#38;gamma of radiation, demonstrated the effect of polysaccharides on a rat&#8217;s spleen lymphocytes, pretreated by the SNAAP, can increase the cell viability compared with irradiated group at a concentration of 20, 60 and 100 &#38;mug/mL. Likewise, this radiation-induced therapy decreased each mouse&#8217;s body weight and effectively stimulated the immune system of all radiated mice. Moreover, when induced by Co60, the SNAAP decreased the level of malondialdehyde (MDA) and increased the myeloperoxidase (MPO) and the glutathione peroxidase (GSH-Px) activity in the whole blood supply of the irradiated mice. Conclusion: These encouraging results support further research into the clinical pharmacology of SNAAP as a novel agent for human radiation protection.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>99</FPAGE>
			<TPAGE>111</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Z.</Name>
				<MidName></MidName>
				<Family>Hua</Family>
				<NameE>Z.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hua</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>W.</Name>
				<MidName></MidName>
				<Family>Zhen-Yu</Family>
				<NameE>W.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Zhen-Yu</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email>wzy219001@yahoo.com.cn</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Y.</Name>
				<MidName></MidName>
				<Family>Xin</Family>
				<NameE>Y.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Xin</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Y.</Name>
				<MidName></MidName>
				<Family>Lin</Family>
				<NameE>Y.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Lin</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Z.</Name>
				<MidName></MidName>
				<Family>Li-Li</Family>
				<NameE>Z.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Li-Li</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>B.</Name>
				<MidName></MidName>
				<Family>Hai-Na</Family>
				<NameE>B.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hai-Na</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>L.</Name>
				<MidName></MidName>
				<Family>Xiao-Yu</Family>
				<NameE>L.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Xiao-Yu</FamilyE>
				<Organizations>
				<Organization>School of Food Science and Engineering, Harbin Institute of Technology, 73 HuangHe Road, NanGang District, Harbin, 150090, P. R. China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Polysaccharides</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>auricularia auricular</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>radioprotection</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>sulfated</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##1. Adhvaryu MR, Srivastav SP, Vaniawala SN, Reddy MN (2008) A comparative study of radioprotection by four Indian       medicinal herbs against genotoxicity induced by sub-lethal gamma irradiation in Swiss albino mice. Iran J Radiat Res, 6: 19-30.##2. Mikkelsen RB and Wardman P (2003) Biological chemistry of reactive oxygen, nitrogen, and radiation-induced signal transduction mechanisms. Oncogene, 22: 5734-5754.##3. Lee JH, Kim SY, Kil IS, Park JW (2007) Regulation of ionizin gradiation-induced apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase. J  Biol  Chem, 282:13385-13394.##4. Zhang R, Kan Kyoung Ah g, Piao MJ, Ko Dong Ok, Wang ZH, Lee In Kyung, et al. (2008) Eckol protects V79-4 lung                           fibroblast cells against-ray radiation-induced apoptosis via the scavenging of reactive oxygen species and inhibiting of the c-Jun NH2-terminal kinase pathway. Eur J Pharmacol, 59: 114-123.##5. Petushkova NA, Bachmanova GI, Archakov AI (1996) 7-Alkoxyphenoxazone and 7-Alkoxycoumarin O-dealkylation by human peripheral blood lymphocytes. In vitro toxicolo 9: 291-295. ##6. Baron JM, Zwadlo-Klarwasser G, Jugert F, Hamann W,                     Rübben A, Mukhtar H, Merk HF (1998) Cytochrome p.450 1B1: A major p.450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol, 56:                              1105-1110. ##7. Dey A, Parmar D, Dhawan A, Dash D, Seth P KA (2002)                       Cytochrome p450 2 E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes. Life Sci, 71: 2509-2519.##8. Sokolov AA (1961) The effect of ionising radiation on stored blood. Problems of Hematology and Blood Transfusion, 6: 186-189.##9. Williams JP, Brown SL, Georges GE, Hauer-Jensen M, Hill RP, Huser AK, Kirsch DG (2010) Animal Models for Medical Countermeasures to Radiation Exposure. Radiat Res, 173:557-578.##10. Hosseinimehr SJ (2007) Trends in the development of                       radio-protective agents. Drug Discov Toda, 12: 794-805.##11. Maurya DK, Devasagayam, TPA, Nair, CK (2006) Some novel approaches for radioprotection and the beneficial effect of natural products. Indian J Exp Biol, 44:93-114.##12. Prasad NR, Mahesh T, Menon VP, Jeevanram RK, Pugalendi K V (2005) Photoprotective effect of sesamol on                                UVB-radiation induced oxidative stress in human blood lymphocytes in-vitro. Environ Toxicol Phar, 20: 1-5.##13. Prasad NR, Ramachandran S, Pugalendi KV, Menon VP (2007) Ferulic acid inhibits UV-B-induced oxidative stress in human lymphocytes. Nutr Res, 27: 559-564.##14. Yamini K and Gopal V, (2010) Natural Radio-protective Agents against Ionizing Radiation–An overview.                             Int J Pharmtech Res, 2: 1421-1426.##15. Ooi VEC and Liu F (2000) Immunomodulation and                             anticancer activity of polysaccharide protein complexes.                     Curr Med Chem, 7: 715-729.##16. Li X L and Zhou GA (2007) Preparation of polysaccharides from Acanthopanax senticosus and its inhibition against irradiation-induced injury of rat. Carbohyd Polym, 67: 219-226.##17. Yan PS, Luo XC, Zhou Q (2004) RAPD molecular                                   differentiation of the cultivated strains of the jelly             mushrooms, Auricularia auricula and A. polytricha. World J Microb Biot, 20: 795-799.##18. Chang JS, Kim HJ, Bae JT, Park SH, Kim SE, Kim OM, Lee KR (1998) Inhibition effects of A.auricula judae-judae          methanol extract on lipid peroxidation and liver damage in benzo(α)pyrene-treated mice. Korean society of food science and nutrition, 27:712-717. ##19. Mau, J L, Chao GR, Wu KT (2001) Antioxidant properties of methanolic extracts from several ear mushrooms. J Agr Food Chem, 49: 5461-5467.##20. Luo YC, Chen G, Li B, Ji BP, Guo Y, Tian F (2009) Evaluation of anti-oxidative and hypolipidemic properties of a novel functional diet formulation of Auricularia auricula and Hawthorn. Innovative Food Science and Emerging                          Technologies, 10: 215-221.##21. Wu Q, Tan Z, Liu H, Gao L, Wu S, Luo J, et al. (2010)           Chemical characterization of Auricularia auricula                      polysaccharides and its pharmacological effect on heart anti-oxidant enzyme activities and left ventricle ejection fraction in aged mice. Int  J of Biol Macromol, 46:                            284-288.##22. Zhang H, Wang ZY, Yang L, Yang X, Wang X, Zhang Z (2011) In-vitro Antioxidant Activities of Sulfated                          Derivatives of Polysaccharides Extracted from Auricularia auricula. Int J Mol Sci, 84: 3287-3202.##23. El-Missiry MA, Fayed TA, El-Sawy MR, El-Sayed AA (2007) Ameliorative effect of melatonin against                                    gamma-irradiation-induced oxidative stress and tissue injury. Ecotoxicol Environ Saf, 66: 278-286.##24. Honda S, Suzuki S, Kakehi K, Honda A, Takai T (1981)             Analysis of the monosaccharide compositions of total non-dialyzable urinary gly-coconjugates by the dithioacetal method. J  Chromatogr, 226: 341-350.##25. Oades JM (1967) Gas-liquid chromatography of alditol acetates and it application to the analysis of sugars in complex hydrolysates. J. Chromatogr, 28: 246-252.##26. Johnes TM and Albersheim P (1972) A gas                                           chromatographic method for the determination of aldose and uronic acid constituents of plant cell wall                                   polysaccharide. Plant Physiol, 49: 926-936.##27. Mozdarani H, Taheri A, Haeri SA (2007) Assessment of radiop-rotective effects of amifostine on human                      lymphocytes irradiated in vitro by gamma-rays using              cytokinesis-blocked micronucleus assay. J  Radiat  Res, 5: 9-16.##28. Becton-Dickinson (1998) Unopette WBC determination for manual methods; Rutherford, N.J.: Becton, Dickinson, and Company. ##29. Berend H (2002) Blood film preparation and staining                      procedures. Clins Lab Med, 22: 1-14.##30. Bain B J (2007) Blood Sampling and Blood Film Preparation and Examination, in Blood Cell A Practical Guide, Fourth Edition, Barbara J. Bain, Oxford, UK.##31. Habu S (1986) in Zaku Seikagaku Jikkenkoza (The Japanese Biochemical Society, ed.) 5: 169.##32. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res, 47: 936-941.##33. Ma M, Liu GH, Yu ZH, Chen G, Zhang X (2009) Effect of the Lycium barbarum polysaccharides administration on blood lipid metabolism and oxidative stress of mice fed high-fat diet in-vivo. Food Chem, 113: 872-877.##34. Zalys R, Zagon IS, Bonneau RH, Lang CM, McLaughlin                     PJ (2000) In-vivo effects of chronic treatment with [Met5]-enkephalin on hematological values and natural killer cell activity in athymic mice. Life Science, 66: 829-834.##35. Ramachandran L, Nair CKK (2012) Radioprotection by  tempol: Studies on tissue antioxidant levels,                                    hematopoietic and gastrointestinal systems, in mice whole body exposed to sub- lethal doses of gamma                         radiation. Iran J Radiat Res, 10: 1-10.##36. Youngston  R (1994) The Antioxidant Health Plan. UK: Harper Collins Publisher.##37. Li X L, Zhou AG, Li XM (2007) Inhibition of Lycium                              barbarum polysaccharides and Ganoderma lucidum polysaccharides against oxidative injury induced by                                 c-irradiation in rat liver mitochondria. Carbohyd Polym, 69: 172-178. ##38. Parihar VK, Dhawan J, Kumar S, Manjula SN, Subramanian G, Unnikrishnan MK, et al. (2007) Free radical scavenging and radio-protective activity of dehydrozingerone against whole body gamma irradiation in Swiss albino mice. Chem  Biol  Interact, 170:49-58. ##39. Prabhakar KR, Veerapur VP, Bansal P, Parihar VK, Reddy Kandadi M, Bhagath Kumar P, et al. (2007) Antioxidant and radio-protective effect of the active fraction of Pilea microphylla (L.)ethanolic extract. Chem Biol  Interact, 165: 22-32.##40. Mozdarani H, Salimi M, Froughizadeh M (2008) Effect of cimetidine and famotidine on survival of lethally gamma irradiated mice. Iran  J  Radiat  Res, 5:187-194.##41. Lizcano LJ, Bakkali F, Ruiz-Larrea MB, Ruiz-Sanz JI (2010) Antioxidant activity and polyphenol content of aqueous extracts from Colombian Amazonian plants with                             medicinal use. Food Chem, 119:1566-1570.##42. Reddy CVK, Sreeramulu D, Raghunath M (2010)                                Antioxidant activity of fresh and dry fruits commonly consumed in India. Food Res Int, 43:285-288.##43. Blomhoff  R (2005) Dietary antioxidant and cardiovascular disease. Curr Opin in Lipidol, 16: 47-54.##44. Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, Browder IW, Williams DL (2001) Glucans exhibit weak antioxidant         activity, but stimulate macrophage free radical activity. Free Radical Bio Med, 30:393-402.##45. Dekkers JC, Doornen LJP, Kemper HCG (1996) The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sport Med, 21: 213-238.##46. Yagi K (1987) Lipid peroxides and human disease.                          Chem Phys Lipids, 45:337-341.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Protective effect of ferulic acid on ionizing radiation induced damage in bovine serum albumin</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Ionizing radiation causes deleterious effects on living system mainly due to oxidative damages of macromolecules and protein is the major target due to its abundance. The aim of this study was to investigate the effects of ionizing radiation induced changes in the molecular properties of bovine serum albumin (BSA) its secondary and tertiary structures, degradation, cross linking and radioprotective role of ferulic acid, a natural antioxidant on these radiation induced changes. Materials and Methods: This study was carried out to investigate the gamma radiation induced oxidative, structural damage of BSA and radioprotective efficacy of ferulic acid through SDS-PAGE, DTNB assay, DNPH assay, FOX assay methods. Hydroxyl radical scavenging capacity of ferulic acid was estimated using 2-deoxy ribose assay. Further, radiation induced changes in the anisotropy and excitation state lifetimes of BSA were examined. Results: SDS &#8211;PAGE data suggested that the loss of protein was linearly dependent on the radiation dose. Gamma-irradiation of BSA caused the formation of protein carbonyls, hydroperoxides and loss of thiols. Ferulic acid protected the radiation induced loss of protein as well as reduced various oxidative damages. Ferulic acid protected the protein from radiation induced damages in a concentration dependent manner. Conclusion: The results provide insight into radiation induced molecular changes in the protein. Ferulic acid protected the BSA from oxidative modification caused by radiation suggesting that ferulic acid possesses strong antiradical properties. Ferulic acid is known to protect DNA, the prime target of radiation and further its ability to protect protein suggesting its ability to protect different biomolecules and therefore can be a good candidate for development radioprotector.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>113</FPAGE>
			<TPAGE>121</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>K.</Name>
				<MidName></MidName>
				<Family>Mishra</Family>
				<NameE>K.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mishra</FamilyE>
				<Organizations>
				<Organization>Chemical Radioprotector and Radiation Dosimetry Research Group, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi-110054, India</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>H.</Name>
				<MidName></MidName>
				<Family>Ojha</Family>
				<NameE>H.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ojha</FamilyE>
				<Organizations>
				<Organization>Chemical Radioprotector and Radiation Dosimetry Research Group, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi-110054, India</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.</Name>
				<MidName></MidName>
				<Family>Kallepalli</Family>
				<NameE>S.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kallepalli</FamilyE>
				<Organizations>
				<Organization>Chemical Radioprotector and Radiation Dosimetry Research Group, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi-110054, India</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.</Name>
				<MidName></MidName>
				<Family>Alok</Family>
				<NameE>A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Alok</FamilyE>
				<Organizations>
				<Organization>Chemical Radioprotector and Radiation Dosimetry Research Group, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi-110054, India</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>N.</Name>
				<MidName></MidName>
				<Family>Kumar Chaudhury</Family>
				<NameE>N.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kumar Chaudhury</FamilyE>
				<Organizations>
				<Organization>Chemical Radioprotector and Radiation Dosimetry Research Group, Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Delhi-110054, India</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email>nkcinmas@rediffmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>BSA</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>protein carbonyl</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>radioprotection</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ferulic acid</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##Finkel T and Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature, 408:239-247.##Taysi S,  Polat F,  Gul M,  Sari RA,  Bakan E (2002) Lipid peroxidation, some extracellular antioxidants and                  antioxidant enzymes in serum of patients with                           rheumatoid arthritis.  Int J Rheumatol, 21: 200–204.##Davies MJ (2005) The oxidative environment and protein damage. Biochim Biophys Acta, 1703: 93–109.##Mayo JC, Tan DX, Sainz RM, Natarajan M,                      Lopez-Burillo S, Reiter RJ  (2003) Protection against                 oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants. Biochim Biophys Acta, 1620: 139-150.##Pachala M and Schessler H (1993) Oxygen effect in the radiolysis of proteins. Int J Radiat Biol, 64:149-156.##Kempner ES (1993) Damage to proteins due to the direct action of ionizing radiation. Q Rev Biophys, 26:27-48.##Hosseinimehr SJ (2007)Trends in the development of radioprotective agents. Drug Discovery Today,                              12:794-805.##Mishra K, Srivastav PS, Chaudhury NK (2011) Sesamol as a potential radioprotective agent: an in-vitro study.                    Radiat Res, 176: 613-623.##Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants and the degenerative diseases of ageing.  Proc Natl Acad Sci USA, 90: 7915-7922.##Halliwell B and Gutteridge JMC (2007) Free radicals in biology and medicine.4th ed. UK, Clarendon Press, Oxford. ##Graf E (2000) Antioxidant potential of ferulic acid. Free Radic Biol Med, 28: 1249–1256. ##Ogiwara T, Satoh K, Kadoma Y, Murakami Y, Unten S, Atsumi T, Sakagami H, Fujisawa S (2002) Radical                   scavenging activity and cytotoxicity of ferulic acid.               Anticancer Res, 22:2711-2717.##Khanduja KL , Avti  PK, Kumar S, Mittal N, Sohi KK, Pathak CM (2006) Anti-apoptotic activity of caffeic acid, ellagic acid and FAin normal human peripheral blood                    mononuclear cells: A Bcl-2 independent mechanism.       Biochim Biophys Acta, 1760: 283-289.## Srinivasan M, Sudheer AR, Menon VP (2007) Ferulic acid: therapeutic potential through its antioxidant property.                J Clin Biochem Nutr, 40: 92–100.##15. Prasad NR, Srinivasan M, Pugalendi KV, Menon VP (2006) Protective effect of ferulic acid on γ-radiation           induced micronuclei, dicentric aberration and lipid                  peroxidation in human lymphocytes. Mutat Res, 603: 129–134.##Maurya DK, Salvi VP, Nair CK (2005) Radiation protection of DNA by FA under in-vitro and in-vivo conditions.                     Mol Cell  Biochem, 280: 209-217.##Baskaran N, Manoharanm S, Balakrishnan S, Pugalendhi P (2010) Chemopreventive potential of FAin 7,                             12-dimethylbenz[a]anthracene-induced mammary                carcinogenesis in Sprague-Dawley rats.  Eur J Pharmacol, 637:  22-29. ##Itagaki S, Kurokawa T, Nakata C, Saito Y, Oikawa S,                Kobayashi M, Hirano T,  Iseki  K (2009)                                          In-vitro and in-vivo antioxidant properties of ferulic acid: a comparative study with other natural oxidation inhibitors.                         Food Chem, 114:  466-471.##Middleton E, Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells:                             implications for inflammation, heart disease and cancer. Pharmacol Rev, 52:673-839.  ##Ojha H, Murari BM, Anand S, Hassan MI, Ahmad F, Chaudhury NK (2009) Interaction of DNA minor groove binder Hoechst 33258 with bovine serum albumin.  Chem Pharm Bull, 57:  481-486. ##Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4.  Nature, 227: 680–685. ##Hawkins CL, Morgan PE, Davies MJ (2009) Quantification of protein modification by oxidants.  Free Radic Biol Med, 46: 965-88. ##Maire LM, Thauvette LD, Foresta B,  Beauregard V,  Potier AGM (1990) Effects of ionizing radiations on proteins.  Biochem J, 267:  431-439.##Lee Y and Song KB (2003) Effect of g-Irradiation on the Molecular Properties of Myoglobin. J Biochem Mol Biol, 35 590-594.##Silvester JA, Timmins GS, Davies MJ (1998)                                      Photodynamically generated bovine serum                                   albumin radicals: evidence for damage transfer and                             oxidation at cysteine and tryptophan residues.  Free Radic Biol Med, 24: 754-766. ##Cho Y, Yang JS, Song  B (1999) Effect of ascorbic acid and protein concentration on the molecular weight profile of bovine serum albumin and b-lactoglobulin by                                       g-irradiation.  Food Res Int, 32: 515-519. ## Perricone N,   Nagy K, Horváth F,  Dajkó G, Uray I,    Zs, Nagy I (1999) Alpha lipoic acid (ALA) protects proteins against the hydroxyl free radical-induced alterations: rationale for its geriatric topical application.  Arch Gerontol Geriatrics, 29, 45–56.##Stadtman ER (2006) Protein oxidation and aging. Free Radical Res, 40:1250-1258.   ##Mishra K, Ojha H, Chaudhury NK (2012) Estimation of antiradical properties of antioxidants using DPPH assay: A critical review and results. Food Chem, 130: 1036-1043.## Ojha H, Mishra K, Hassan MI, Chaudhury NK (2012)                        Spectroscopic and isothermal titration calorimetry studies of binding interaction of ferulic acid with bovine serum albumin. Thermochim Acta, 548:56-64.##Kapoor S and Priyadarsini KI (2001) Protection of                                  radiation-induced protein damage by curcumin.                            Biophys Chem, 30;119-126.##Salvi A, Carrupt P , Tillement J  Testa B (2001) Structural damage to proteins caused by free radicals: assessment, protection by antioxidants, and influence of protein                       binding. Biochem Pharmacol, 61:1237-1242.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Alterations of PSA, CA15.3, CA125, Cyfra21-1, CEA, CA19.9, AFP and Tag72 tumor markers in human blood serum due to long term exposure to high levels of natural background radiation in Ramsar, Iran</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Ramsar (Mazandran province) is known for its extremely high levels of natural background radiation. Although no excess cancer rate is reported in these areas by epidemiological studies, the study of tumor markers in the inhabitants of these areas may shed some light on the impact of high levels of background radiation on cancer induction. Materials and Methods: The level of background gamma radiation as well as indoor radon was determined using RDS-110 and CR-39 dosimeters. Thirty five individuals from a high background radiation area (HBRA) and 53 individuals from a normal background radiation area (NBRA) were randomly selected to participate in the study. Commercial ELISA kits (sandwich type ELISA tests) were used to measure the serum levels of PSA, CA15.3, CA125, Cyfra21-1, CEA, CA19.9, AFP and Tag72 tumor markers. Results: Among the eight biomarkers investigated, the means of PSA, CA15.3, CA125, CA19.9 and AFP concentrations between the HBRAs and NBRAs were not significantly different. However, Cyfra21, CEA and Tag72 in HBRA group revealed statistically significant increases compared to those of NBRA group (P&#60;0.05). Furthermore, a statistically significant correlation between the external gamma dose as well as indoor radon level and the concentration of CEA (P&#60;0.001), Cyfra-21(P&#60;0.001) and TAG 72 (P&#60;0.001 and 0.01 respectively) biomarkers were observed. Conclusion: Chronic exposure to high background radiation induces significant alterations in Cyfra21, CEA and Tag72 levels. We believe that studies with other relevant tumor markers might overcome the limitations of epidemiological studies on cancer incidence in high background radiation areas.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>123</FPAGE>
			<TPAGE>128</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>S.</Name>
				<MidName></MidName>
				<Family>Taeb</Family>
				<NameE>S.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Taeb</FamilyE>
				<Organizations>
				<Organization>The Center for Research in Radiation Sciences (CRRS), School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.M.J.</Name>
				<MidName></MidName>
				<Family>Mortazavi</Family>
				<NameE>S.M.J.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mortazavi</FamilyE>
				<Organizations>
				<Organization>The Center for Research in Radiation Sciences (CRRS), School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>mmortazavi@sums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.</Name>
				<MidName></MidName>
				<Family>Ghaderi</Family>
				<NameE>A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghaderi</FamilyE>
				<Organizations>
				<Organization>Cancer Institute, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>H.</Name>
				<MidName></MidName>
				<Family>Mozdarani</Family>
				<NameE>H.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mozdarani</FamilyE>
				<Organizations>
				<Organization>Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>CE.</Name>
				<MidName></MidName>
				<Family>de Almeida</Family>
				<NameE>CE.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>de Almeida</FamilyE>
				<Organizations>
				<Organization>Laboratório de Ciências Radiológicas (LCR) da Universidade do Estado do RJ (UERJ), Rio de Janeiro, Brazil</Organization>
				</Organizations>
				<Countries>
				<Country>Brazil</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.R.</Name>
				<MidName></MidName>
				<Family>Kardan</Family>
				<NameE>M.R.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Kardan</FamilyE>
				<Organizations>
				<Organization>National Radiation Protection Department (NRPD), Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.A.R.</Name>
				<MidName></MidName>
				<Family>Mortazavi</Family>
				<NameE>S.A.R.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mortazavi</FamilyE>
				<Organizations>
				<Organization>Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.</Name>
				<MidName></MidName>
				<Family>Soleimani</Family>
				<NameE>A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Soleimani</FamilyE>
				<Organizations>
				<Organization>Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>I.</Name>
				<MidName></MidName>
				<Family>Nikokar</Family>
				<NameE>I.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nikokar</FamilyE>
				<Organizations>
				<Organization>Laboratory of Immunology and Microbiology of Infectious Diseases, Paramedicine Faculty, Guilan University of Medical Sciences, Guilan, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.</Name>
				<MidName></MidName>
				<Family>Haghani</Family>
				<NameE>M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Haghani</FamilyE>
				<Organizations>
				<Organization>The Center for Research in Radiation Sciences (CRRS), School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Ramsar</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>tumor markers</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>high background radiation areas (HBRAs)</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>gamma radiation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Radon</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##1.	Rapkiewicz AV, Espina V, Petricoin EF, 3rd, Liotta LA (2004) Biomarkers of ovarian tumours. Eur J Cancer, 40(17): 2604-12.##2.	Dupont J, Tanwar MK, Thaler HT, Fleisher M, Kauff N, Hensley ML, et al. (?)Early detection and prognosis of ovarian cancer using serum YKL-40. J Clin Oncol, 22(16): 3330-9.##3.	Sohrabi M (2013) World high background natural radiation areas: Need to protect public from radiation exposure. Radiation Measurements, 50(0):166-71.##4.	Mortazavi SMJ and Mozdarani H (2012) Is it time to shed some light on the black box of health policies regarding the inhabitants of the high background radiation areas of            Ramsar? International Journal of Radiation Research, 10(3):111-6.##5.	Mortazavi SMJ and Mozdarani H  (2013) Non-linear           phenomena in biological findings of the residents of high background radiation areas of Ramsar. International Journal of Radiation Research, 11: 3-9.##6.	Ghiassi-Nejad M, Mortazavi SMJ, Cameron JR, Niroomand-Rad A, Karam PA (2002) Very high background radiation areas of Ramsar, Iran: Preliminary biological studies. Health Physics, 82(1):87-93.##7.	Hendry JH, Simon SL, Wojcik A, Sohrabi M, Burkart W, Cardis E, et al. (2009) Human exposure to high natural background radiation: what can it teach us about radiation risks? J Radiol Prot, 29(2A): A29-42.##8.	Nair MK, Nambi KS, Amma NS, Gangadharan P, Jayalekshmi P, Jayadevan S, et al. (1999) Population study in the high natural background radiation area in Kerala, India. Radiat Res, 152(6 Suppl): S145-8.##9.	Nair RR, Rajan B, Akiba S, Jayalekshmi P, Nair MK, Gangadharan P, et al. (2009) Background radiation and cancer incidence in Kerala, India-Karanagappally cohort study. Health Phys, 96(1): 55-66.##10. Mortazavi SMJ, Ghiassi-Nejad M, Rezaiean M (2005) Cancer risk due to exposure to high levels of natural radon in the inhabitants of Ramsar, Iran. International Congress Series, 1276: 436-7.##11. Nair RR and Johnson JK (2008) A dictionary to tumor markers and the methods of estimation. Advanced Biotech, 24: 22-32.##12. Mortazavi S, Ghiassi Nejad M, Beitollahi M (2001) Very High Background Radiation Areas (VHBRAs) of Ramsar: Do We Need any Regulations to Protect the Inhabitants.         Proceedings of the 34th midyear meeting, Radiation Safety and ALARA Considerations for the 21st Century, California, USA, 177-82.##13. Mortazavi S, Ghiassi-Nejad M, Ikushima T, Assaie R,          Heidary A, Varzegar R, et al. (2003) Are the inhabitants of high background radiation areas of ramsar more radioresistant? Scope of the problem and the need for future studies.  Iranian Journal of Radiology, 1: 37-44.##14. Mortazavi S (2005) Ramsar Hot Springs: How Safe is to Live in an Environment with High Level of Natural Radiation. Nippon Genshiryoku Kenkyujo JAERI, Conf 194-204.##15. Mortazavi S, Shabestani-Monfared A, Ghiassi-Nejad M, Mozdarani H (2005) Radioadaptive responses induced in human lymphocytes of the inhabitants of high level natural radiation areas in ramsar, Iran. Asian Journal of Experimental Sciences, 19:19-39.##16. Mortazavi SMJ, Abbasi A, Asadi R, Hemmati A (2005) The need for considering social, economic, and psychological factors in warning the general public from the possible risks due to residing in HLNRAs. International Congress Series, 1276: 440-1.##17. Mortazavi SMJ, Ghiassi-Nejad M, Rezaiean M (2005) Cancer risk due to exposure to high levels of natural radon in the inhabitants of Ramsar, Iran. In: Sugahara T, Morishima H, Sohrabi M, Sasaki Y, Hayata I, Akiba S, editors, p. 436-7.##18. Mortazavi SMJ and Karam PA (2005) Apparent lack of radiation susceptibility among residents of the high background radiation area in Ramsar, Iran: can we relax our standards? In: Simopoulos ES, editor. Radioactivity in the Environment, 7: 1141-7.##19. Mortazavi SMJ, Ghiassi-Nejad M, Karam PA, Ikushima T, Niroomand-Rad A, Cameron JR (2006) Cancer incidence in areas with elevated levels of natural radiation. International Journal of Low Radiation, 2: 20-7.##20. Mortazavi SMJ, Mosleh-Shirazi MA, Mehdizadeh S, Rouintan MS, Ebrahimi J, Tamaddon M, et al. (2010) Short-term radon inhalation induces significant survival adaptive response in Balb/c mice. International Journal of Low Radiation, 7: 98-109.##21. Mortazavi SMJ and Mozdarani H (2012) Is it time to shed some light on the black box of health policies regarding the inhabitants of the high background radiation areas of Ramsar? Iranian Journal of Radiation Research.;10(3-4):111-6.##22. Mortazavi SMJ, Niroomand-Rad A, Mozdarani H, Roshan-Shomal P, Razavi-Toosi SMT, Zarghani H (2012) Short-term exposure to high levels of natural external gamma radiation does not induce survival adaptive response. International Journal of Radiation Research, 10: 165-70.##23. Lai RS, Hsu HK, Lu JY, Ger LP, Lai NS. (1996) CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer. Chest, 109: 995-1000.##24. de Affonseca MS, Alves RN, Junior JT, de Almeida CE (2002) The influence of urbanization on natural radiation levels in anomalous areas. Journal of Environmental Radioactivity, 63: 65-75.##25. Raghu Ram Nair K, Akiba S, Binu VS, Jayalekshmi P,         Gangadharan P, Krishnan Nair M, et al. (2005) Individual dose estimation—our experience with the Karunagappally study in Kerala, India. International Congress Series, 1276: 41-5.##26. Tao Z, Akiba S, Zha Y, Sun Q, Zou J, Li J, et al. (2012) Cancer and non-cancer mortality among Inhabitants in the high background radiation area of Yangjiang, China (1979-1998). Health Phys, 102: 173-81.##27. Sohrabi M and Babapouran M (2005) New public dose assessment from internal and external exposures in low- and elevated-level natural radiation areas of Ramsar, Iran. International Congress Series, 1276:169-74.##28. Tao Z, Zha Y, Akiba S, Sun Q, Zou J, Li J, et al. (2000) Cancer mortality in the high background radiation areas of Yangjiang, China during the period between 1979 and 1995. J Radiat Res, 41: 31-41.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Quantitative SPECT and planar 32P bremsstrahlung imaging for dosimetry purpose –An experimental phantom study</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: In this study, Quantitative 32P bremsstrahlung planar and SPECT imaging and consequent dose assessment were carried out as a comprehensive phantom study to define an appropriate method for accurate Dosimetry in clinical practice. Materials and Methods: CT, planar and SPECT bremsstrahlung images of Jaszczak phantom containing a known activity of 32P were acquired. In addition, Phantom contour was determined for attenuation correction and image registration. Reconstructed SPECT slices were corrected for attenuation effect using two different methods: conventional Chang`s method and an expectation maximization algorithm followed by CT and SPECT image registration. Cumulated activity was calculated by a predefined calibration factor. Both attenuation correction algorithms were quantitatively assessed by the Monte Carlo SIMIND program. Acquired planar Bremsstrahlung images were quantified by the Conjugate View Method, as well. Results: Calculated activities were statistically different among various quantification methods (P= 0.0001). When iterative expectation maximization algorithm and applied methods were used, mean calculated activity had the least difference with real activity of &#177;3%. Conclusion: Quantitative 32P Bremsstrahlung SPECT imaging could accurately determine administered activity and assess radiation dose if precise attenuation correction and appropriate registration with CT were done even without sophisticated scatter correction or when SPECT/CT machines are not available. Therefore, it has the potential of specific tumor/organ dosimetry in clinical practice. The best method for calculating activity is quantitative SPECT using iterative expectation maximization algorithm. Additionally, applied method for determining phantom contour was practical for attenuation correction and image registration.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>129</FPAGE>
			<TPAGE>138</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>M.R.</Name>
				<MidName></MidName>
				<Family>Teimoori Sichani</Family>
				<NameE>M.R.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Teimoori Sichani</FamilyE>
				<Organizations>
				<Organization>Department of Medical Radiation Engineering, Science and Research branch, Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.</Name>
				<MidName></MidName>
				<Family>Amoui</Family>
				<NameE>M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Amoui</FamilyE>
				<Organizations>
				<Organization>Department of Nuclear Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sh.</Name>
				<MidName></MidName>
				<Family>Akhlaghpoor</Family>
				<NameE>Sh.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akhlaghpoor</FamilyE>
				<Organizations>
				<Organization>Noor Medical Imaging Center, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>akhlaghpoor@pardisnoor.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.</Name>
				<MidName></MidName>
				<Family>Hosntalab</Family>
				<NameE>M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hosntalab</FamilyE>
				<Organizations>
				<Organization>Department of Medical Radiation Engineering, Science and Research branch, Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Bremsstrahlung imaging</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>quantitative SPECT imaging</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>attenuation correction</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Phosphorus-32</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>activity determination</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>dosimetry</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##1.	Hamami ME, Poeppel TD, Muller S, Heusner T, Bockisch A, Hilgard P, et al. (2009) SPECT/CT with 99mTc-MAA in                radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med, 50(5): 688-92.##2.	Akhlaghpoor S, Aziz-Ahari A, Amoui M, Tolooee S,                       Poorbeigi H, Sheybani S (2012) Short-term effectiveness of radiochemoembolization for selected hepatic metastases with a combination protocol. World J Gastroenterol,                   18 (37):5249-59.##3.	D'Asseler Y (2009) Advances in SPECT imaging with                    respect to radionuclide therapy. Q J Nucl Med Mol                    Imaging, 53(3): 343-7.##4.	Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the                    radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys, 68(1):13-23.##5.	Murthy R, Habbu A, Salem R (2006) Trans-arterial hepatic radioembolisation of yttrium-90 microspheres. Biomed Imaging Interv J, 2(3): e43.##6.	Minarik D, Ljungberg M, Segars P, Gleisner KS (2009) Evaluation of quantitative planar 90Y bremsstrahlung whole-body imaging. Phys Med Biol, 54(19): 5873-83.##7.	Minarik D, Sjogreen Gleisner K, Ljungberg M (2008)                Evaluation of quantitative (90)Y SPECT based on                        experimental phantom studies. Phys Med Biol, 53(20): 5689-703.##8.	Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ (1994) Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med, 35(8): 1381-9.##9.	Siegel JA  (1994) Quantitative bremsstrahlung SPECT                  imaging: attenuation-corrected activity determination. J Nucl Med, 35(7):1213-6.##10.	Siegel JA, Zeiger LS, Order SE, Wallner PE (1995)                           Quantitative bremsstrahlung single photon emission                 computed tomographic imaging: use for volume, activity, and absorbed dose calculations. Int J Radiat Oncol Biol Phys, 31(4): 953-8.##11.	Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, et al. (1999) MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med, 40(2): 37S-61S.##12.	Bruyant PP. (2002) Analytic and iterative reconstruction algorithms in SPECT. J Nucl Med, 43(10): 1343-58.##13.	Chang LT (1978) A Method Attenuation Correction in                Radionuclide Computed Tomography. IEEE Trans Nucl Sci, NS-25: 638-42.##14.	Siegel JA and Khan SH (1996) Body contour determination and validation for bremsstrahlung SPECT imaging. J Nucl Med, 37(3):495-7.##15.	Fleming JS (1979) A technique for the absolute                        measurement of activity using a gamma camera and                 computer. Phys Med Biol, 24(1): 176-80.##16.	Siegel JA, Whyteellis S, Zeiger LS, Order SE, Wallner PE (1994) Bremsstrahlung SPECT imaging and volume                    quantitation with 32 phosphorus. Antibody                                  Immunoconjugates and Radiopharmaceuticals,7(1): 1-10.##17.	Fleming JS (1989) A technique for using CT images in attenuation correction and quantification in SPECT.                     Nucl Med Commun, 10(2): 83-97.##18.	Crum WR, Camara O, Hill DL (2006) Generalized overlap measures for evaluation and validation in medical image analysis. IEEE Trans Med Imaging, 25(11): 1451-61.##19.	Dice LR (1945) Measures of the Amount of Ecologic Association Between Species Ecology, 26:297-302.##20.	Zijdenbos AP, Dawant BM, Margolin RA, Palmer AC (1994) Morphometric analysis of white-matter lesions in                        MR-images - method and validation. IEEE Trans Med                   Imaging, 13(4): 716-24.##21.	Ljungberg M and Strand SE (1989) A Monte Carlo program for the simulation of scintillation camera characteristics. Comput Methods Programs Biomed, 29(4):257-72.##22.	Bai CY, Shao L, Da Silva AJ, Zhao Z (2003) A generalized model for the conversion from CT numbers to linear attenuation coefficients. Ieee Transactions on Nuclear Science, 50(5): 1510-5.##Berger MJ, Hubbell JH, Seltzer SM, Chang J, Coursey JS, Sukumar R, et al. XCOM: Photon Cross Sections                          Database. The National Institute of Standards and                      Technology (NIST) March 1998 [updated November 2010].##24.	Canny J (1986) A computational approach to edge                detection. IEEE Trans Pattern Anal Mach Intell, 8(6): 679-98.##25.	Mansberg R, Sorensen N, Mansberg V, Van der Wall H (2007) Yttrium 90 Bremsstrahlung SPECT/CT scan                        demonstrating areas of tracer/tumour uptake. Eur J Nucl Med Mol Imaging, 34(11):1887.##26.	Parsai EI, Ayyangar KM, Dobelbower RR, Siegel JA (1997) Clinical fusion of three-dimensional images using Bremsstrahlung SPECT and CT. J Nucl Med, 38(2): 319-24.##27.	Frey EC and Tsui BMW(Conference Record 1997 )A new method for modeling the spatially-variant,                                   object-dependent scatter response function in SPECT.                  In: DelGuerra A, editor. 1996 Ieee Nuclear Science                      Symposium - Conference Record, Vols 1-3. Ieee Nuclear Science Symposium, p. 1082-6.##28.	Zanzonico PB, Bigler RE, Sgouros G, Strauss A (1989)    Quantitative SPECT in radiation dosimetry. Semin Nucl Med, 19(1):47-61.##29.	DeNardo GL, DeNardo SJ, Macey DJ, Mills SL(1988)                   Quantitative Pharmacokinetics of Radiolabeled                      Monoclonal Antibodies for Imaging and Therapy in                   Patients. In: Srivastava SC, editor. Radiolabeled                        Monoclonal Antibodies for Imaging and Therapy. 152. New York: Plenum Press; 1988.##30.	Macey DJ, DeNardo GL, DeNardo SJ (1990) A treatment planning program for radioimmunotherapy. Front Radiat Ther Oncol, 24:123-31; discussion 61-5.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>An investigation into the potential applicability of gel dosimeters for dosimetry in boron neutron capture therapy</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: The aim of this work was to establish how well gel dosimeters performed, as substitutes for brain tissue compared with standard phantom materials such as water, polymethyl-methacrylate (or PMMA), A150 plastic and TE- liquid phantom material for dosimetry of neutron beams in boron neutron capture therapy.  Materials and Methods: Thermal neutron fluence, photon dose and epithermal neutron dose distributions were computed for the epithermal neutron beam of the optimized linac based BNCT. Results: Amongst all investigated phantom materials, TE-liquid was shown to be a better substitute for brain tissue than other phantom materials. The differences between TE- liquid and brain at the depth of 6.1 cm for thermal neutron fluence, gamma dose and epithermal neutron dose distributions was calculated 2.80%, 2.40% and -13.87% , respectively. In comparison with the other gel dosimeters, LMD2 provided a better simulation of radiation transport in the brain. It&#39;s results differed from the real brain, at the depth of 6.1 cm, for thermal neutron fluence, gamma dose and epithermal neutron dose distributions, by -1.27%, 4.20% and 21.05% respectively. Conclusion: Even though, in gamma dose distribution the LMD2 has large deviation from brain tissue distribution, the deviation is approximately independent of depth, so the results can be multiplied by a constant coefficient to be more consistent with reality. Even though, TE- liquid showed satisfactory results for brain tissue substitution in BNCT, but some properties of gel dosimeters such as three dimensionality, make LMD2 a potentially good dosimeter for dosimetric verification in BNCT.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>139</FPAGE>
			<TPAGE>149</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>S.M.</Name>
				<MidName></MidName>
				<Family>Abtahi</Family>
				<NameE>S.M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abtahi</FamilyE>
				<Organizations>
				<Organization>University of Shahid Beheshti, Radiation Medicine Department, P. O. Box 19839- 63113, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>sm_abtahi@sbu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.M.R.</Name>
				<MidName></MidName>
				<Family>Aghamiri</Family>
				<NameE>S.M.R.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aghamiri</FamilyE>
				<Organizations>
				<Organization>University of Shahid Beheshti, Radiation Medicine Department, P. O. Box 19839- 63113, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>H</Name>
				<MidName></MidName>
				<Family>Khalafi</Family>
				<NameE>H</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Khalafi</FamilyE>
				<Organizations>
				<Organization>Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>F.</Name>
				<MidName></MidName>
				<Family>Rahmani</Family>
				<NameE>F.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Rahmani</FamilyE>
				<Organizations>
				<Organization>University of Shahid Beheshti, Radiation Medicine Department, P. O. Box 19839- 63113, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Gel dosimetry</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>BNCT</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>phantom</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MCNP</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>dose distribution</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##1.	Wojnecki C and Green S  (2001)  A computational study into the use of polyacrylamide gel and A-150 plastic as brain tissue substitutes for boron neutron capture therapy. Phys Med Biol, 46:1399–1405. ##2.	Sellakumar P, Samuel EJJ, Supe SS (2007) Water equivalence of polymer gel dosimeters. Radiation Physics and Chemistry, 76: 1108-1115. ##3.	Brown S, Venning A, Deene YD, Vial P, Oliver L, Adamovics J, et al.  (2008)  Radiological properties of the PRESAGE and PAGAT polymer dosimeters. Applied Radiation and Isotopes, 66:1970– 1974. ##4.	Venning AJ, Nitschke KN, Keall PJ, Baldock C  (2005)  Radiological properties of normoxic polymer gel dosimeters. Medical Physics, 32(4):1047-53. ##5.	Pantelis E, Karlis AK, Kozicki M, Papagiannis P, Sakelliou L, Rosiak JM  (2004)  Polymer gel water equivalence and relative energy response with emphasis on low photon energy dosimetry in brachytherapy. Physics in Medicine and Biology, 49: 3495-3514. ##6.	UusiSimola J, Heikkinen S, Kotiluoto P, Serén T, Seppälä T, Auterinen I, et al.  (2007)  MAGIC polymer gel for dosimetric verification in boron neutron  capture therapy. Journal of Applied Clinical Medical Physics, 8(2): 114-123.##7.	Uusi-Simola J, Savolainen S, Kangasm¨aki A, Heikkinen S (2003) Study of the relative dose-response of BANG-3R polymer gel dosimeters in epithermal neutron irradiation. Phys Med Bio, 48: 2895–2906. ##8.	Farajollahi AR, Bonnett DE, Tattam D, Greenk S (2000) The potential use of polymer gel dosimetry in boron neutron capture therapy. Phys Med Biol, 45: N9–N14. ##9.	Baldock C, Deene YD, Doran S, Ibbott G, Jirasek A, Lepage M, et al.  (2010)  Polymer gel dosimetry. Phys Med Biol, 55:R1–R63. ##10. Ibbott GS (2004) Application of gel dosimetry. Journal of Physics, Conference Series 3: 58-77. ##11. Maryanski MJ, Schulz RJ, Ibbott GS, Gatenby JC, Xie J, Horton D, et al.  (1994)  Magnetic resonance imaging of radiation dose distributions using a polymer-gel dosimeter. Physics in Medicine and Biology, 39:1437-1455. ##12. Marya˜nski MJ, Zastavker YZ, Gore JC (1996) Radiation dose distributions in three dimensions from tomographic optical density scanning of polymer gels: II. Optical properties of the BANG polymer gel. Phys Med Biol, 41:2705–2717. ##13. Maryanski MJ, Ibbott GS, Eastman P, Scultz RJ, Gore JC (1996) Radiation therapy dosimetry using magnetic resonance imaging of polymer gels. Med Phys, 23:699–705. ##14. Bruce P (2003) The use of BANG-3 polymer gel to quantify the three-dimensional dose distribution of IMRT. [MSc. Thesis]. Louisiana: Louisiana State University, 27-28.##15. Pappas E, Maris T, Angelopoulos A, Paparigopoulou M, Sakelliou L, Sandilos P, et al.  (1999)  A new polymer gel for magnetic resonance imaging (MRI) radiation dosimetry. Phys Med Biol, 44: 2677–2684. ##16. Deene YD, Vergote K, Claeys C, Wagter Cd  (2006) The fundamental radiation propertiesof normoxic polymer gel dosimeters: a comparison between a methacrylic acid based gel and acrylamide based gels. Phys Med Biol, 51: 653-673. ##17. Fong PM, Keil DC, Does MD, Gore JC (2001) Polymer gels for magnetic resonance imaging of radiation dose distributions at normal room atmosphere. Physics in Medicine and Biology, 46(12):3105-3113. ##18. Venning AJ, Hill B, Brindha S, Healy BJ, Baldock C (2005) Investigation of the PAGAT polymer gel dosimeter using magnetic resonance imaging. Physics in Medicine and Biology Printed in the UK, 50: 3875-3888. ##19. Venning AJ, Brindha S, Hill B, Baldock C (2004) Preliminary study of a normoxic PAG gel dosimeter with tetrakis (hydroxymethyl) phosphonium chloride as an antioxidant. Journal of Physics, Conference Series 3: 155–158. ##20. Venning A, Healy B, Nitschk K, Baldock C (2005) Investigation of the MAGAS normoxic polymer gel dosimeter with Pyrex glass walls for clinical radiotherapy dosimetry. Nuclear Instruments and Methods in Physics Research A, 555(1-2): 396-402. ##21. Šolc J and Spˇev´aˇcek Va  (2009)  New radiochromic gel for 3D dosimetry based on Turnbull blue: basic properties. Phys Med Biol, 54: 5095–5107. ##22. Gorjiara T, Hill R, Kuncic Z, Adamovics J, Bosi S, Kim J-H, et al.  (2011)  Investigation of radiological properties and water equivalency of PRESAGE® dosimeters. Med Phys, 38 (4)##23. Vandecasteele J, Ghysel S, Baete SH, Deene YD (2011) Radio-physical properties of micelle leucodye 3D integrating gel dosimeters. Phys Med Biol, 56: 627–651. ##24. Raaijmakers CPJ, Nottelman EL, Mijnheer BJ (2000) Phantom materials for boron neutron capture therapy. Phys Med Biol, 45:2353–2361. ##25. Taylor ML, Franich RD, Johnston PN, Millar RM, Trapp JV (2007) Systematic variations in polymer gel dosimeter calibration due to container influence and deviations from water equivalence. Phys Med Biol, 52: 3991–4005. ##26. ICRU (1989) Tissue substitutes in radiation dosimetry and measurement. Report No.: ICRU Report 44 (Bethesda, MD: ICRU).##27. X-5 Monte Carlo Team. MCNP—A General Monte Carlo N-Particle Transport Code, Version 5, Volume I: Overview and Theory. Los Alamos, N.M.: Los Alamos National Laboratory; 2003. Report No.: LA-UR-03-1987.##28. Rahmani Fand Shahriari M (2011) Beam shaping assembly optimization of Linac based BNCT and in-phantom depth dose distribution analysis of brain tumors for verification of a beam model. Annals of Nuclear Energy, 38: 404–409. ##29. Goorley JT, Kiger WS, Zamenhof RG (2002) Reference            dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models. Med Phys, 29(2): 145-156##30. Goorley JT (2007) MCNP Medical Physics Database: Los Alamos National Laboratory, Report No.: LA-UR-07-2777.##31. ICRU63 (2000) Nuclear data for neutron and proton radiotherapy and for radiation protection. MD Bethesda: International Commission on Radiation Units and Measurements, 63.##32. Nuclear Energy Agency (NEA) (2010). JANIS-3.2. In  Hauts-de-Seine,##33. Gustavsson H, Ba¨ck SAJ, Medin J, Grusell E, Olsson LE  (2004)  Linear energy transfer dependence of a normoxic polymer gel dosimeter investigated using proton beam  absorbed dose measurements. Phys  Med  Biol, 49:3847–3855. ## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Effect of uniform magnetic field on dose distribution in the breast radiotherapy</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: To reduce the dose to normal tissues surrounding the treated breast, a uniform magnetic field was used within a humanoid phantom in breast radiotherapy. Materials and Methods: Monte Carlo simulations were performed with GEANT4, irradiating humanoid phantoms in a magnetic field. To reconstruct phantoms, computed tomography (CT) data slices of four patients were used for the Monte Carlo simulations. All of them had left breast cancer either or not mastectomy. In the simulations, the planning and methods of chest wall irradiation were similar to the actual clinical planning. Results: Utilizing magnetic field will help to produce uniform dose distribution to the breast with a sharp dose-volume histogram (DVH) curve for the planning target volume (PTV), however, for the ipsilateral lung and chest wall skin the mean dose was reduced by a mean of 16% and 12% at 1.5 T, and 9% and 7% at 3 T, respectively. The magnetic field was shown to restrict the lateral spread of secondary electrons to the contralateral organs, resulting in significient dose reductions to the contralateral breast (CB) and contralateral chest wall skin (CCWS) by a mean (range) of 28% (21-37%) and 58% (44-75%) at 1.5 T, and 48% (32-81) and 66% (54-73%) at 3 T, respectively. Conclusion: The simulations established that the magnetic field can reduce the dose to the internal and contralateral tissues and increase it to the PTV with sharper edge DVH curve.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>151</FPAGE>
			<TPAGE>160</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>A.D.</Name>
				<MidName></MidName>
				<Family>Esmaeeli</Family>
				<NameE>A.D.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Esmaeeli</FamilyE>
				<Organizations>
				<Organization>Department of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>ali_esmaeeli_d@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.</Name>
				<MidName></MidName>
				<Family>Pouladian</Family>
				<NameE>M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Pouladian</FamilyE>
				<Organizations>
				<Organization>Department of Medical Radiation Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.S.</Name>
				<MidName></MidName>
				<Family>Monfared</Family>
				<NameE>A.S.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Monfared</FamilyE>
				<Organizations>
				<Organization>Department of Medical Physics, Babol University of Medical Sciences, Babol, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>S.R.</Name>
				<MidName></MidName>
				<Family>Mahdavi</Family>
				<NameE>S.R.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mahdavi</FamilyE>
				<Organizations>
				<Organization>Department of Medical Physics, Tehran University of Medical Sciences, Tehran, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>D.</Name>
				<MidName></MidName>
				<Family>Moslemi</Family>
				<NameE>D.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moslemi</FamilyE>
				<Organizations>
				<Organization>Department of Radiation Oncology, Babol University of Medical Sciences, Babol, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>ERE</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>magnetic field</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>breast</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>GEANT4</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>##Boice JD, Harvey EB,  Blettner M, Storall M, Flannery JT (1992) Cancer in the CB after radiotherapy for breast    cancer. N Engl J Med, 326: 781-5.##Pignol JP, Keller BM, Ravi A (2011) Doses to internal organs for various breast radiation techniques implications on the risk of secondary cancers and cardiomyopathy. Radi Oncol, 6:5-11. ##3. Sohn JW, Macklis R, Suh JH, Kupelian P (1999) A mobile shield to reduce scatter radiation to the contralateral breast during radiotherapy for breast cancer: preclinical results. Int J Radiat Oncol Biol Phys, 43: 1037-41.##4. Muller-Runkel R and Kalokhe UP (1994) Method for                      reducing scatter radiation dose to the contralateral breast during tangential breast irradiation therapy. Radiology, 191:853-5.##5. Macklis RM, Crownover RL, Crowe J, WILoughby T, Sohn J (1999) Reducing scatter radiation to the contralateral breast with a mobile, conformal shield during breast                    cancer radiotherapy. Am J Clin Oncol, 22:419-25.##6. Hall EJ (2006) Intensity-modulated radiation therapy,                      protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys, 65: 1-7.##7. Xu XG, Bednarz B, Paganetti H (2008) A review of dosimetry studies on external beam radiation treatment with                           respect to second cancer induction. Phys Med Biol, 53: R193-241.##8. Shih CC (1975) High energy electron radiotherapy in a          magnetic field. Med Phys, 2: 9-13.##9. Chen Y, Bielajew AF, Litzenberg DW, Moran JM, Becchetti FD (2005) Magnetic confinement of electron and photon radiotherapy dose: A Monte Carlo simulation with a                         nonuniform longitudinal magnetic field. Med Phys, 12: 3810-3818.##10. Pouliot J, Bani-Hashemi A, Chen J, Svatos M, Ghelmansarai F, Mitschke M, Aubin M, Xia P, Morin O, Bucci K, Roach M, Hernandez P, Zheng Z, Hristov D, Verhey L (2005) Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys, 61: 552-560.##11. Nederveen AJ, Dehnad H, Van der Heide UA, Van Moorselaar RJA, Hofman P, Lagendijk JJW (2003)                            Comparison of megavoltage position verification for                              prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol, 68: 81–8.##12. Lagendijk JJW, Raaymakers BW, Raaijmakers AJE,                        Overweg J, Brown K J, Kerkhof EM, van der Put RW,                        Hårdemark B, van Vulpen M, van der Heide UA (2007) MRI/Linac integration. Radiother Oncol, doi:10.1016/ j radonc, 10.034.##13. Fallone B, Carlone M, Murray B, Rathee S, Stanescu T, Steciw S,Wachowicz K, Kirkby C (2007) Development of a linac-MRI system for real-time ART.  AAPM Minneapolis 49th Annual Meeting.##14. Fallone B G, Murray B, Rathee S, Stanescu T, Steciw  S, Vidakovic S, Blosser E, Tymofichuk D (2009) First MR                           images obtained during megavoltage photon irradiation from a prototype integrated linac-MR system. Med Phys, 36: 2084–2088.##15. Kirkby C, Stanescu T, Fallone B G (2009) Magnetic field effects on the energy deposition spectra of MV photon radiation. Phys Med Biol, 54: 243–257.##16. Kirkby C, Murray B, Rathee S, Fallone BG (2010) Lung     dosimetry in a linac-MRI radiotherapy unit with a                            longitudinal magnetic field. Med Phys, 37: 4722-3.##17. Kirkby C, Stanescu T, Rathee S, Carlone M, Murray B,               Fallone BG (2008) Patient dosimetry for hybrid                                    MRI-radiotherapy systems. Med Phys, 35: 1019-27.##18. Oborn BM, Metcalfe PE, Butson MJ, Rosenfeld AB (2009) High resolution entry and exit Monte Carlo dose                               calculations from a linear accelerator 6 MV beam under the influence of transverse magnetic fields. Med. Phys. 36: 3549-59.##19. Oborn BM, Metcalfe PE, Butson MG, Rosenfeld AB, Keall PJ (2012) Electron contamination modeling and skin dose in 6 MV longitudinal field MRIgRT: Impact of the MRI and MRI fringe field. Med Phys, 39: 874-91.##20. Whitmire DP, Bernard DL, Peterson MD (1993) Magnetic Modification of the Electron-dose Distribution in Tissue and Lung Phantoms. Med Phys, 5: 409-17.##21. Bieljajew A F (1993) The Effect of Strong Longitudinal    Magnetic Fields on Dose Deposition From Electron and Photon Beams. Med Phys, 20: 1171-9.##22. Li XA, Reiffel L, Chu J, Naqvi S (2001) Conformal                            photon-beam therapy with transverse magnetic fields: a Monte Carlo study. Med Phys, 28: 127–33.##23. Jette D (2000) Magnetic fields with photon beams: dose calculation using electron multiple-scattering theory. Med Phys, 27: 1705–1716.##24. Raaijmakers A J E, Raaymakers BW, Lagendijk J JW (2008) Magnetic-field-induced dose effects in MR-guided                               radiotherapy systems: dependence on the magnetic field strength. Phys Med Biol, 53: 909–923.##25. Raaijmakers AJ, Raaymakers BW, Lagendijk JJ (2005)               Integrating a MRI scanner with a 6 MV radiotherapy                   accelerator: Dose increase at tissue-air interfaces in a lateral magnetic field due to returning electrons.  Phys Med Biol, 50: 1363–1376.##26. Raaymakers BW, Raaijmakers AJ, Kotte AN, Jette D,                        Lagendijk JJ (2004) Integrating a MRI scanner with a 6 MV radiotherapy accelerator: Dose deposition in a transverse magnetic field. Phys Med Biol, 49: 4109–4118.##27. Agostinelli, Allison J, Amako Apostolakis J, Araujo H, Arce P, Asai M,  Axen D, Banerjee S, Barrand G, Behner F,           Bellagamba L, Boudreau J, Broglia L, et al. (2003) GEANT4- a simulation toolkit. Nucl Instrum Methods Phys Res A, 506: 250–303.##28. Raaijmakers AJE, Raaymakers BW, Lagendijk JJW (2007c) Experimental verification of magnetic field dose effects for the MRI-accelerator. Phys Med Biol, 52: 4283–4291.##29. Raaijmakers AJE, Hårdemark B, Raaymakers BW, Raaijmakers CPJ, Lagendijk JJW (2007a) Dose optimization for the MRI-accelerator: IMRT in the presence of a                          magnetic field. Phys Med Biol, 52: 7045–7054.	##30. Sardari D, Maleki R, Samavat H, Esmaeeli A (2010)                          Measurement of depth-dose of linear accelerator and simulation by use of GEANT4 computer code. Rep Pract Oncol Radiother, 15: 64–68.##31.  The Geant4 web site and Manual, http://geant4.web.cern.ch/geant4/UserDocUserDocUse/UsersGuides/ForApplication.##32.International Commission on Radiation Units and                           Measurements (1992) Photon, electron, proton and                         neutron interaction data for body tissues. Bethesda, MD : ICRU, report: 46.##33. Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE (1997) Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy J. Clin. Oncol. 15: 1348-1353.##34. Harris EE, Correa C, Hwang WT, Liao J, Litt HI, Ferrari VA, Solin LJ (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment J Clin Oncol, 24: 4100- 4106##35. Travis LB, HIL DA, Dores GM, Gospodarowicz M, van        Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Wiklund T, Lynch CF, Van’t Veer MB, Glimelius I, Storm H, Pukkala E, Stovall M, Curtis R, Boice JD Jr and Gilbert E (2003) Breast cancer following radiotherapy and                           chemotherapy among young women with Hodgkin disease  JAMA, 290: 465–475.##36.  Dasu A, Toma-Dasu I, Olofsson J, Karlsson M (2005) The use of risk estimation models for the induction of                         secondary cancers following radiotherapy Acta. Oncol, 44: 339-47.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Impact of range straggling and multiple scattering on proton therapy of brain, using a slab head phantom</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: The advantages of proton beam in radiation therapy- like small lateral scattering as well as absence of exit dose tail in the organs which are after the tumor- make it capable of delivering more treatment doses to the target and much lesser to the critical tissues near it. Materials and Methods: In this study, the Monte Carlo MCNPX code has been used to simulate a slab head phantom irradiated by proton pencil beams. The simplified slab has tissue compositions of the ICRU 46, and the necessary data have been taken from adult male phantom of MIRD-ORNL family series. Results: Suitable energy range of incident proton beams has been estimated in order to have the Bragg peaks inside the brain tissue. Energy straggling or, rather, range straggling, and multiple scattering which affect the lateral broadening of incident beams, have been investigated. Conclusion: The results show that the FWHM (Full Wide in Half Maximum) increases more than six times from 1.73 mm to 10.78 mm for the energy range of 50 - 135 MeV. The FWHM values of lateral dose profiles change from 1 mm in 50 MeV to 7.5 mm in 135 MeV, and it has been shown that when a pencil beam is used to irradiate a tissue, the absorbed dose in depth along the central axis does not show a Bragg peak pattern.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>161</FPAGE>
			<TPAGE>167</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>S.B.</Name>
				<MidName></MidName>
				<Family>Jia</Family>
				<NameE>S.B.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jia</FamilyE>
				<Organizations>
				<Organization>Department of Physics , Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.A.</Name>
				<MidName></MidName>
				<Family>Mowlavi</Family>
				<NameE>A.A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mowlavi</FamilyE>
				<Organizations>
				<Organization>Department of Physics , Hakim Sabzevari University, Sabzevar, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email>amowlavi@hsu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.H.</Name>
				<MidName></MidName>
				<Family>Hadizadeh</Family>
				<NameE>M.H.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hadizadeh</FamilyE>
				<Organizations>
				<Organization>Department of Physics , Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.</Name>
				<MidName></MidName>
				<Family>Ebrahimi Loushab</Family>
				<NameE>M.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ebrahimi Loushab</FamilyE>
				<Organizations>
				<Organization>Department of Physics , Ferdowsi University of Mashhad, Mashhad, Iran</Organization>
				</Organizations>
				<Countries>
				<Country>Iran</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>MCNPX code</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>proton therapy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>slab head phantom</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>range straggling</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>multiple scattering</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Haberer T (2002) Advances in Charged Particles Therapy. Nuclear Physics in 21st Century. Int Nucl Phys Conf INPC 2001. AIP Conf Proc, 610: 157-166.##Kraft G (2000) Tumor Therapy with Heavy Charged                    Particles. Progress in Particle and Nuclear Physics,                        45: S473-544.##Wilson RR (1946) Radiological use of fast protons.                    Radiology, 47: 487–491.##Tobias CA, Lawrence JH, Born JL, McCombs R, Roberts JE, Anger HO, Huggins C (1958) Pituitary Irradiation with High Energy Proton Beams: a Preliminary Report.                                  Cancer Research, 18: 121-134.##Smith AR (2009) Vision 20/20: Proton therapy. Med Phys, 36(2): 556-568.##Paganetti H and Bortfeld T (2005) Proton Beam                               Therapy – The state of the Art, New technologies in                           radiation oncology. Medical Radiology Series, Springer Verlag, Heidelberg; ISBN3-540-00321-5.##Bortfeld T (1997) An analytical approximation of the Bragg curve for therapeutic proton beams. Med Phys,                                      24(12): 2024-2033.##Bichsel H, Attix FH, Roesch WC (1968) Charged-particle       interactions. In: Radiation Dosimetry. Eds. Academic Press, New York. 1: 157–228.##Gottschalk B, Koehler AM, Schneider RJ, Sisterson JM, Waner MS (1993) Multiple coulomb scattering of 160 MeV protons. Nuclear Instruments and methods in physics Research B 74: 467-490.##Weber U (1996) Volumenkonforme Bestrahlung mit Kohlenstoffionen. PhD Thesis, Universitat Gh Kassel.##Chu WT, Ludewigt BA, Renner TR (1993) Instrumentation for Treatment of Cancer Using Proton and Light-Ion Beams: Review of Scientific instruments, Accelerator &#38; Fusion Research Division, LBL-33403 UC-406.##Sawakuchi GO, Mirkovic D, Perles LA, Sahoo N, Zhu XR, Ciangaru G, et al. (2010) An MCNPX Monte Carlo model of a discrete spot scanning proton beam therapy nozzle. Med Phys, 37(9): 4960–4970.##Sawakuchi GO, Titt U, Mirkovic D, Ciangaru G, Zhu X R, Sahoo N et al. (2010) Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams.                      Phys Med Biol, 55: 711–721.##Waters LS, Hendricks J, Kinney GMC (2002) Monte Carlo N-Particle Transport Code system for  Multiparticle and High Energy Applications, Los Alamos. NM: Los Alamos National Laboratory. ##White GRDR, Wilson IJ (1992) Photon, Electron, Proton and Neutron Interaction Data for Body Tissues. ICRU                        Report 46. Bethesda, Maryland, USA.##Eckerman KF, Cristy M,  Ryman JC (1996) The ORNL                     mathematical phantom series. available at:                                http://homer.ornl.gov/vlab/mird2.pdf. ##Evans RD (1982) The atomic nucleus. McGraw-Hill, USA. ##Slopsema R (2011) Beam delivery using passive scattering. In:Proton therapy physics (Ed. Paganetti H); CRC Press/Taylor &#38; Francis, 1-18.##Paganetti H (2009) Dose to water versus dose to medium in proton beam therapy. Phys Med Biol, 54: 4399-4421.##Torfimov A and Borfeld T (2003) Beam delivery                               sequencing for intensity modulated proton therapy. Phys Med Biol, 48: 1321-1331. ##Vatnitsky SM, Miller DW, Moyers MF, Levy RP, Schulte RW, et al. (1999) Dosimetry techniques for narrow proton beam radiosurgery. Phys Med Biol, 44: 2789–2801.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Design of homogeneous and heterogeneous human equivalent thorax phantom for tissue inhomogeneity dose correction using TLD and TPS measurements</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: The purpose of this study is to fabricate inexpensive in-house low cost homogeneous and heterogeneous human equivalent thorax phantom and assess the dose accuracy of the Treatment Planning Systems (TPS) calculated values for different lung treatment dosimetery. It is compared with Thermoluminescent Dosimeter (TLD) measurement. Materials and Methods: Homogeneous and heterogeneous thorax human equivalent phantoms were fabricated using bee&#8217;s wax (density=0.99 g/cm3) as a tissue simulating material, with inserts of cork (density=0.2 g/cm3) and Teflon (density=2 g/cm3) as lung and spine simulating material respectively. Lithium fluoride (LiF) TLD capsules were irradiated for different thoracic tumor treatment techniques using the locally fabricated homogeneous and heterogeneous phantoms. The 3D TPS calculated values of homogeneous and heterogeneous phantoms were compared with TLD measured values. Results: Experiments were carried out for different thoracic tumour treatment techniques for small and larger field sizes and also with and without wedge for Cobalt &#8211; 60 photon beams. Plato TPS were used to calculate the inhomogeneity for the homogeneous and heterogeneous phantoms. TLD and 3D TPS calculated values were found to have deviation of &#177; 5%. Conclusion: Both the homogeneous and heterogeneous phantoms has proved to be a valuable tools in the development and implementation of external beam radiotherapy (EBRT) in the clinical thorax region and in the verification of absolute dose and dose distributions in the regions of clinical and dosimetric interest.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>169</FPAGE>
			<TPAGE>178</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>S.</Name>
				<MidName></MidName>
				<Family>Senthilkumar</Family>
				<NameE>S.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Senthilkumar</FamilyE>
				<Organizations>
				<Organization>Department of Radiotherapy, Madurai Medical College and Govt. Rajaji Hospital, Maduari-625 020, India</Organization>
				</Organizations>
				<Countries>
				<Country>India</Country>
				</Countries>
				<EMAILS>
				<Email>sasenthilgh@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Homogeneous phantom</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>heterogeneous phantom</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>TLD</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>thoracic region tumour</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>TPS</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Geroge X Ding, Dennis M Duggan, Bo Lu (2007) Impact of inhomogeneity corrections on dose coverage in the     treatment of lung cancer using stereotactic body radiation therapy. Med Phys, 34(7): 2985-2994.##2. Senthilkumar S and Ramakrishnan V (2011) Fabrication of low cost in-house slab  homogeneous and heterogeneous phantoms for lung radiation treatment.  Iran J Radiat Res, 9(2): 109-119.##3. Don Robinson (2008) Inhomogeneity correction and the analytic anisotropic algorithm. J Appl Clin Med Phys,                      9(2): 112—122.  ##4. Tissue inhomogeneity corrections for megavoltage photon beams AAPM report no. 85, (2004) Madison, USA: AAPM.##5. Anuj Kumar, Sunil Dutt Sharma, Arya AK, Surabhi Gupta, Deepak Shrotriya (2011) Effect of low-density                                     heterogeneities in telecobalt therapy and validation of dose calculation algorithm of a treatment planning                      system. J Med Phys, 36(4): 198–204.##6. Svenesson GK (1984) Quality assurance in radiation therapy: physical effort. Int J Radiat Oncol Biol Phys,                           10(suppl 1): 23-29. ##7. Brahme A, Chavaudra J, Landberg T (1988) Accuracy                           requirements and quality assurance of external beam therapy with photons and electrons. Acta Oncol,                                  (Suppl 1): 1-76. ##8. Venselaar J, Welleweerd H, Mijnheer B (2001) Tolerances for the accuracy of photon beam dose calculations of                                 treatment planning systems. Radiother Oncol,                             60: 191-201.##9. Andrew O Jones, Indra J Das, Frederick L Jones (2003)                               A Monte Carlo study of IMRT beamlets in inhomogeneous media. Med Phys, 30(3): 296-300.##10.  ICRU Report 42 (1987) Use of computers in external beam radiotherapy procedures with high energy photons and electrons. Washington, DC: International Commission on Radiation Units and Measurement.##11. Ekstrand KE and Barnes WH (1990) Pitfalls in the use of high energy X-rays to treat tumors in the lung. Int J Radiat Oncol Biol Phys, 18: 249-252.##12. El-Khatib EE, Evans M, Pla M (1989) Evaluation of lung dose correction methods for photon irradiation of thorax                            phantoms. Int J Radiat Oncol Biol Phys, 17: 871-878.##13. Anctil J, Clark BG, Arsenault CJ (1998) Experimental determination of dosimetry functions of Ir-192 sources.                                Med Phys, 25: 2279-2287.##14. Karaiskos P (1998) Monte Carlo and TLD dosimetry of an 192Ir high dose rate brachytherapy source. Med Phys,                              25: 1975-1984. ##15. Kirov AS, Williamson JF, Meigooni AS (1995) TLD, diode and Monte Carlo dosimetry of an 192Ir for high dose rate                     brachytherapy. Phys Med Biol, 40: 2015-2036. ##16. David Followill, DeeAnn Radford Evans (2007) Design,                       development, and implementation of the Radiological Physics Center’s pelvis and thorax anthropomorphic quality assurance phantoms. Med Phys, 34(6):  2070-2076. ##17. Nath R (1995) Dosimetry of interstitial brachytherapy source: Recommendations of AAPM radiation therapy              committee task group no. 43. Med Phys, 22: 209-234. ##18. ICRU  Report 48 (1992) Phantoms and computational                       models in therapy, diagnosis and protection. Maryland, USA. International Commission on Radiation Units and Measurement, 15.##19. Pradhan AS (1995) Influence of heating rate on the                             response of TLDs. Radiat Prot Dosim, 58: 205-209.##20. Photon treatment planning collaborative working group (1991) Role of inhomogeneity corrections in                                      three–dimensional photon treatment planning. Int J Radiat  Oncol  Biol  Phys, 21: 59-69. ## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Production of yttrium aluminum silicate microspheres by gelation of an aqueous solution containing yttrium and aluminum ions in silicone oil</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Radioactive yttrium glass microspheres are used for liver cancer treatment. These yttrium aluminum silicate microspheres are synthesized from yttrium, aluminum and silicone oxides by melting. There are two known processes used to transform irregular shaped glass particles into microspheres, these &#8216;spheroidization by flame&#8217; and &#8216;spheroidization by gravitational fall in a tubular furnace&#8217;. Materials and Methods: Yttrium aluminum silicate microspheres with the approximate size of 20-50 &#181;m were obtained when an aqueous solution of YCl3 and AlCl3 was added to tetraethyl orthosilicate (TEOS) and pumped in to silicone oil and stirred constantly the temperature of 80˚C. The resulting spherical shapes were then investigated for crystallization, chemical bonds, composition and distribution of elements by scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), carbon/sulfur analysis, X-ray photoelectron spectroscopy (XPS) and SEM/EDS analysis. Results: The particles produced by the above-mentioned method were regular and nearly spherical in shape. The results of topographical analysis of a cross-section showed that form of the microspheres had formed a &#8216;boiled egg&#8217; structure. This method has an advantage over other methods in that the process does not require high temperatures. Conclusion: This paper reports on a novel method to produce yttrium glass microspheres. The resulting microspheres were formed with a silicon crust so the proposed method is expected to be suitable for application in the production of radioactive seed sources for implantation in tumors and cancer tissue.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>179</FPAGE>
			<TPAGE>187</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>M.R.</Name>
				<MidName></MidName>
				<Family>Ghahramani</Family>
				<NameE>M.R.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghahramani</FamilyE>
				<Organizations>
				<Organization>Institute of Radiation Problems, Azerbaijan National Academy of Sciences, Baku, Azerbaijan</Organization>
				</Organizations>
				<Countries>
				<Country>Azerbaijan</Country>
				</Countries>
				<EMAILS>
				<Email>ghahramani.mr@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>A.A.</Name>
				<MidName></MidName>
				<Family>Garibov</Family>
				<NameE>A.A.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Garibov</FamilyE>
				<Organizations>
				<Organization>Institute of Radiation Problems, Azerbaijan National Academy of Sciences, Baku, Azerbaijan</Organization>
				</Organizations>
				<Countries>
				<Country>Azerbaijan</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>T.N.</Name>
				<MidName></MidName>
				<Family>Agayev</Family>
				<NameE>T.N.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Agayev</FamilyE>
				<Organizations>
				<Organization>Institute of Radiation Problems, Azerbaijan National Academy of Sciences, Baku, Azerbaijan</Organization>
				</Organizations>
				<Countries>
				<Country>Azerbaijan</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Yttrium microspheres</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>brachytherapy microspheres</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>seed source</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>sol gel technique</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Day DE, Gary R, Ehrhardt J (1988) Radioactive glass                    microspheres. U S Pat No 5011677.##2. Erbe EM and Day ED (1993) Chemical durability of                       Y2O3-Al2O3-SiO2 glasses for the in-vivo delivery of beta radiation. J Biomed Mater Res, 27: 1301-1308.##3. Kawashita M, Miyaji F, Kokubo T, Takaoka GH, Yamada I, Suzuki Y, Kajiyama K (1997) Preparation of glass for                      radiotherapy of cancer by P + Ion implantation at 100 keV. Nucl Instrum Meth Phys Res, B 121: 323-327.##4. Kawashita M, Miyaji F, Kokubo T (1999) Preparation of Phosphorus-Containing Silica Glass Microspheres for                      Radiotherapy of Cancer by Ion Implantation.  J Mater Sci Mater Med, 10: 459-463.##5. Kawashita M, Miyaji F, Kokubo T, Takaoka GH, Yamada I, Suzuki Y, Inoue M (1999) Surface structure and chemical durability of P+ - implanted Y2O3–Al2O3–SiO2 glass for                    radiotherapy of cancer. J Non-Cryst Solids, 255: 140-148.##6. Kawashita M, Takayama Y, Kokubo T, Takaoka GH, Araki N, Hiraoka M (2006) Enzymatic preparation of hollow yttrium oxide microspheres for in situ radiotherapy of deep-seated cancer. J Am Ceram Soc, 89: 1347–1351.##7. Kawashita M, Miyaji F, Kokubo T, Takaoka GH, Yamada I, Suzuki Y, Kajiyama K (1997) Preparation of radiotherapy glass by phosphorus ion implantation at 100 keV. J Biomed Mater Res, 38: 342-347.##8. Kawashita M, Matsui N, Li Zh, Miyaza T (2010) Preparation of porous yttrium Oxide microparticles by gelation of                       ammonium alginate in aqueous solution containing yttrium Ions. J Mater Sci: Mater Med, 21: 1837–1843.##9. Christie JK and Tilocca A (2010) Short-range structure of yttrium alumino-silicate glass for cancer radiotherapy:                 Car–Parrinello Molecular Dynamics Simulations. Adv Eng Mater, 12: B326-B330.##10. Simon V, Eniua D, Takácsb A, Magyari K, Neumannb M, Simon S (2005) X-Ray Photoemission Study of  Yttium                   Contained in Radiotherapy Systems. J Optoelectron Adv Mater, 7: 2853–2857.##11. Heness G and Ben-Nissan B (2004) Innovative Bioceramics. Mater Forum, 27: 104-114.##12. Sene FF, Martinelli JR, Okuno E (2008) Synthesis and characterization of phosphate glass microspheres for                          radiotherapy applications. J Non-Cryst Solids, 354: 4887-4893.##13. Kawashita M, Shineha R, Kim HM, Kokubo T, InoueY, Araki N, Nagata Y, Hiraoka M, Sawada Y (2003) Preparation of ceramic microspheres for in situ radiotherapy of                            deep-seated cancer. Biomate, 24: 2955-2963.##14. Sreekumar KP, Saxena SK, Kumar Y, Thiyagarajan TK, Dash A, Ananthapadmanabhan PV, Venkatesh M (2010) studies on the preparation and plasma spherodization of yttrium aluminosilicate glass microspheres for their potential                        application in liver brachytherapy. J Phys Conf Ser, 208: 1-5.##15. Mantravadi RVP, Spignos DG, Tan WS, Felix EL (1982)                   Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiol, 142: 783-786.##16. Cho SM, Kim YT, Yoon DH (2003) Optical characterization of silica based waveguide prepared by plasma enhanced chemical vapor deposition. J Korean Phys Soc,                                         42: S947-S951.##17. Karl A, Gschneidner Jr, Eyring LR (1986) Handbook on the physics and chemistry of rare earths. Vol 8 Elsevier Science Publishers B.V.##18. Palanivel R and Velraj G (2007) FTIR and FT-Raman                      spectroscopic studies of fired clay artifacts recently                           excavated in Tamilnadu, India. Indian J Pure &#38; Appl Phys, 45: 501-508.##19. Gradeff PS, Yunlu K, Deming TJ, Olofson JM, Doedens RJ, Evans WJ (1990) Synthesis of yttrium and lanthanide silyloxy complexes from anhydrous nitrate and oxo alkoxide                        precursors and the X-ray crystal structure of[ Ce( OSiPh3),( THF) 3]( THF). Inorg Chem, 29: 420-424.##20. Chambers JJ (2000) Reactions for yttrium silicate                           high-K dielectrics. PHD theses, North Carolina State                       University, Raleigh.##21.http://vasculardiseasemanagement.com/content/                 does-microparticle-size-affect-bland-emboli                                   zation-outcomes-local-treatment-liver-malignancie##22. Yang CS, Kim JS, Choi JW, Kwon MH, Kim YJ, Choi JG, Geug T Kim (2002) XPS study of aluminum oxides deposited on PET thin film. J Ind and Eng Chem, 6: 149-156.##23. Shpotyuk O, Filipecki J, Klym H, Ingram A (2009) Combined XRD, XPS and pals characterization of humidity sensitive MgAl2O4 ceramics. Ser Phys, 43: 199-208.##24. Van Den Brand J, Snijders PC, Sloof WG, Terryn H, de Wit JHW (2004) Acid-Base Characterization of Aluminum Oxide Surfaces with XPS. J Phys Chem B, 108: 6017-6024.##25. D. Niu, Ashcraft RW, and Parsons GN (2002) Water                        absorption and interface reactivity of yttrium oxide gate dielectrics on silicon. Appl Phys Lett, 80: 3575-3577.##26. Niu D, Ashcraft RW, Chen Z, Stemmer S, Parsons GN (2003) Chemical, physical, and electrical characterizations of                  oxygen plasma assisted chemical vapor deposited yttrium oxide on silicon. J Electrochem Soc, 150: F102-F109.##27. Zaharieva K and Vissokov G (2008) Preparation and                          characterization of plasma-chemically synthesized                         nanodispersed powders of ZrO2-Y2O3 and SiO2. Annu Univ Min Geol, 51: 87-91. ##28. Simon V, Eniua D, Takácsb A, Magyari K, Neumannb M, Simon S (2005) Iron doping on the electronic structure in yttrium aluminosilicate glasses. J Non-Cryst Solids, 351: 2365-2372.##29. Lide DR ed. (2007) CRC Handbook of Chemistry and                     Physics, 87th Edition. Taylor and Francis, Boca Raton, FL..##30. Niu D (2002) Interface reactions during processing of chemical vapor deposited yttrium oxide high-k dielectrics. PHD Theses. North Carolina State University, Raleigh.##31. Zhang H, Guo X, Zhang Q, Ma Y, Zhou H, Li J, Wang L, Deng Y (2008) Synthesis of dialkyl hexamethylenedicarbamate from 1,6-hexamethylenediamine and alkyl carbamate over Y(NO3)3·6H2O catalyst. J Mol Catal A: Chem, 296: 36-41.##32. Chambers JJ, Busch BW, Schulte WH, Gustafssom T,                    Garfunkel E, Wang S, Maher DM, Klein TM, Parsons GN (2002) Effect of surface pretreatments on interface                      structure during formation of ultra-thin yttrium silicate dielectric films on silicon. Appl Surf Sci, 181: 78-93.##33. Chambers JJ and Parsons GN (2001) Physical and electrical characterization of ultrathin yttrium silicate insulators on silicon. J Appl Phys, 90: 918-933.##34. Gulec SA and Siegel JA (2007) Post therapy radiation safety considerations in radiomicrosphere treatment with                        90Y-microspheres. J Nucl Med, 48: 2080-2086.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Primary embryonal rhabdomyosarcoma of the kidney in an adult：A case report</TitleF>
		<TitleE></TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Primary rhabdomyosarcoma (RMS) of the kidney is a rare malignant mesenchymal tumor with an aggressive clinical course. Adult renal RMS is typically a pleomorphic histologic subtype and only a few cases have ever been reported. We herein present a new case of renal RMS of the embryonal histologic subtype in a 26-year-old woman.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>189</FPAGE>
			<TPAGE>192</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1393/3/7
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/282014/05/28
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1393/3/7
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Sh.</Name>
				<MidName></MidName>
				<Family>Fang</Family>
				<NameE>Sh.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fang</FamilyE>
				<Organizations>
				<Organization>Department of Ultrasound, the Affiliated Hospital of Qingdao University Medical College, 16 Jiang Su Road, Qingdao, Shandong Province 266003, China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email>cloudylucn@163.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Y.</Name>
				<MidName></MidName>
				<Family>Sun</Family>
				<NameE>Y.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sun</FamilyE>
				<Organizations>
				<Organization>Department of Ultrasound, the Affiliated Hospital of Qingdao University Medical College, 16 Jiang Su Road, Qingdao, Shandong Province 266003, China</Organization>
				</Organizations>
				<Countries>
				<Country>China</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>M.P.H.</Name>
				<MidName></MidName>
				<Family>Yuan Wang</Family>
				<NameE>M.P.H.</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yuan Wang</FamilyE>
				<Organizations>
				<Organization>The University of Texas Medical School at Houston, Houston, Texas, U.S.A.</Organization>
				</Organizations>
				<Countries>
				<Country>U.S.A.</Country>
				</Countries>
				<EMAILS>
				<Email></Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Embryonal rhabdomyosarcoma</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>kidney</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>tumor</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>adult</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>Kramer S, Meadows AT, Jarrett P, Evans AE (1983)              Incidence of childhood cancer: experience of a               decade in a population-based registry. J Natl Cancer Inst, 70:49-55.##2. Linardic CM (2008) PAX3-FOXO1 fusion gene in  rhabdomyosarcoma. Cancer Lett, 270: 10-18.##3. Vogelzang NJ, Fremgen AM, Guinan PD, Chmiel JS, Sylvester JL, Sener SF (1993) Primary renal sarcoma in adults: A natural history and management study by the American Cancer Society, Illinois Division. Cancer, 71: 804-810.##4. Dalfior D, Eccher A, Gobbo S, Brunelli M, Martignoni G, Menestrina F, Dalla PP, Dvornik G (2008)                           Primary pleomorphic rhabdomyosarcoma of the kidney in an adult. Ann Diagn Pathol, 12(4): 301-3.##5. Stout AP (1946) Rhabdomyosarcoma of the Skeletal Muscles. Ann Surg, 123: 447-472. ##6. du Boulay CE (1985) Immunohistochemistry of soft tissue tumours: A review. J Pathol, 146:77-94. ##7. Horn RC Jr and Enterline HT (1958)                                         Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases. Cancer, 11:181-199.##8. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J, Heyn R (1995) The third intergroup Rhabdomyosarcoma study. J Clin Oncol, 13: 610-630.##9. Furlong MA, Mentzel T, Fanburg-Smith JC (2001) Pleomorphic rhabdomyosarcoma in adults: a                          clinicopathologic study of 38 cases with emphasis on          morphologic variants and recent skeletal muscle-specific markers. Mod Pathol, 14:595-603. ##10. Meir K, Wygoda M, Reichman O, Gofrit ON, Pizov G (2006) Puerperal renal rhabdomyosarcoma: case report and         review of the literature. Urol Oncol, 24: 40-43. ##11. Grignon DJ, McIsaac GP, Armstrong RF, Wyatt JK (1988) Primary rhabdomyosarcoma of the kidney. A light microscopic, immunohistochemical, and electron microscopic study. Cancer, 62: 2027-2032.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
